Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3026179	s-normet	nmol/l (nmol/l)	5488	7043	0.07%
3026179	s-normet	— (—)	283	307	100.00%	Distribution not available
3026179	s-normet	umol/l (nmol/l)	6	9	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypertension, essential

1517

1806

4.92

307.65

1.3

0.99

1.19

nmol/l

0.11

1458

1753

Benign neoplasm of other and unspecified endocrine glands

1128

500

28.68

307.65

1.5

1.3

0.64

0.60

nmol/l

0.84

1102

475

Hypertension

1485

1853

4.64

307.65

1.3

1.00

1.18

nmol/l

0.11

1431

1800

Hypertensive diseases

1484

1854

4.64

307.65

1.3

1.00

1.18

nmol/l

0.11

1431

1801

Hypertensive diseases (excluding secondary)

1156

1157

5.98

307.65

1.2

1.3

1.10

1.54

nmol/l

0.17

1116

1123

Benign neoplasm of other and unspecified endocrine glands

1128

473

30.34

307.65

1.5

1.3

0.64

3.92

nmol/l

0.69

1102

453

Cardiovascular diseases (excluding rheumatic etc)

1059

1442

4.32

307.65

1.3

0.74

1.32

nmol/l

0.32

1023

1395

Antihypertensive medication - note that there are other indications

933

1063

4.89

307.65

1.3

0.53

1.58

nmol/l

0.48

901

1026

Benign neoplasm: Adrenal gland

1010

257

62.72

307.65

1.4

1.3

0.64

nmol/l

0.05

985

243

Secondary hypertension

309

168

19.87

307.65

1.3

4.06

0.59

nmol/l

0.50

291

161

Benign neoplasm: Adrenal gland

1010

272

59.22

307.65

1.4

1.3

0.64

0.66

nmol/l

0.31

985

257

Cardiovascular diseases

908

1184

4.25

272.91

1.3

0.53

1.49

nmol/l

0.50

881

1146

Disorders of other endocrine glands

835

2201

3.84

267.39

1.7

1.2

0.85

1.89

nmol/l

0.76

807

2110

Metabolic disorders

1379

3203

2.72

223.12

1.3

1.36

1.16

nmol/l

0.09

1321

3101

Hyperaldosteronism

169

22.52

220.06

1.3

1.2

0.55

0.61

nmol/l

0.46

159

Malaise and fatigue

773

1837

3.58

215.02

1.3

1.67

2.25

nmol/l

0.17

734

1764

Headache

976

2692

3.08

214.82

1.3

1.42

1.71

nmol/l

0.11

946

2590

Abnormalities of heart beat

599

1475

4.13

213.50

1.3

2.65

1.48

nmol/l

0.31

574

1421

General symptoms and signs

1521

2996

2.58

208.61

1.3

0.57

1.59

nmol/l

1.23

1474

2889

Benign neoplasms

1322

2756

2.71

207.13

1.4

1.2

2.23

0.86

nmol/l

0.61

1278

2650

Exclusions for E4_PCOS_BROAD

400

757

5.52

200.90

2.2

1.2

1.10

0.59

nmol/l

0.66

389

730

Pain in throat and chest

1170

2608

2.78

197.16

1.3

0.93

1.09

nmol/l

0.11

1126

2515

Other heart diseases

656

1128

3.91

191.88

1.3

0.60

1.54

nmol/l

0.46

627

1094

Benign neoplasms

1051

2092

2.88

184.26

1.4

1.2

2.62

0.85

nmol/l

0.64

1020

2006

Other disorders of fluid, electrolyte and acid-base balance

510

1212

4.17

182.71

1.2

1.3

0.97

1.96

nmol/l

0.45

483

1158

Abnormalities of breathing

1185

2687

2.65

181.83

1.3

0.59

1.07

nmol/l

0.66

1134

2590

Endocrine, nutritional and metabolic diseases

1055

1939

2.80

170.22

1.3

1.2

0.74

1.16

nmol/l

0.30

1016

1877

Symptoms and signs involving the circulatory and respiratory systems

1319

2701

2.47

167.62

1.3

1.73

1.07

nmol/l

0.30

1273

2604

Cardiac arrhythmias

876

2007

2.93

165.84

1.3

1.2

2.24

1.13

nmol/l

0.37

841

1947

Hypokalaemia

269

436

6.48

159.37

1.2

1.3

1.22

0.65

nmol/l

0.44

259

420

Anaemias

294

303

6.56

150.88

1.3

1.2

0.60

4.28

nmol/l

0.48

277

291

Medical observation and evaluation for suspected diseases and conditions

929

1758

2.74

144.53

1.3

0.57

2.21

nmol/l

1.13

907

1686

Other disorders of adrenal gland

156

149

11.43

144.50

3.3

1.2

1.91

0.58

nmol/l

0.66

151

141

Other heart diseases, wide

1219

3372

2.27

136.53

1.3

1.79

1.03

nmol/l

0.36

1166

3275

Disorders of lipoprotein metabolism and other lipidaemias

1045

2748

2.42

135.64

1.3

1.61

1.27

nmol/l

0.12

1006

2657

Other arrhythmias

886

2717

2.53

132.81

1.3

2.25

1.15

nmol/l

0.38

846

2633

Neoplasms

912

1887

2.62

132.60

1.5

1.1

0.56

0.88

nmol/l

0.71

883

1812

Hypothyroidism (congenital or acquired)

309

327

5.50

126.17

1.4

1.2

3.87

4.01

nmol/l

0.01

298

313

GASTRO-related operations

983

2009

2.48

125.83

1.3

1.2

0.57

2.07

nmol/l

1.21

950

1934

Any gastric operation

983

2009

2.48

125.83

1.3

1.2

0.57

2.07

nmol/l

1.21

950

1934

Hypertensive heart and/or renal disease

323

547

4.67

125.15

1.3

1.2

3.29

2.73

nmol/l

0.06

307

525

Episodal and paroxysmal disorders

1359

3300

2.13

124.57

1.3

1.71

1.00

nmol/l

0.34

1311

3166

Dyspnoea

1122

3960

2.20

122.32

1.3

1.50

1.32

nmol/l

0.08

1075

3817

Diseases of arteries, arterioles and capillaries (FINNGEN)

339

535

4.52

121.52

1.3

3.78

2.71

nmol/l

0.11

319

520

Hypothyroidism and >3 levothyroxin purchases

297

324

5.34

117.96

1.5

1.2

4.02

4.04

nmol/l

0.00

286

310

Hypothyroidism, levothyroxine purchases

297

324

5.34

117.96

1.5

1.2

4.02

4.04

nmol/l

0.00

286

310

Abnormal blood-pressure reading, without diagnosis

137

145

10.14

117.63

1.2

1.4

8.97

0.67

nmol/l

0.48

130

137

Diseases of oesophagus, stomach and duodenum

1322

3930

2.06

116.94

1.3

1.38

1.10

nmol/l

0.13

1264

3794

Cerebrovascular diseases (FINNGEN)

394

746

3.84

116.30

1.4

1.2

0.62

2.10

nmol/l

0.48

379

722

Other diseases of intestines

1280

3657

2.05

110.63

1.3

0.59

1.40

nmol/l

1.20

1228

3535

Hypertensive Heart Disease

276

490

4.70

109.93

1.3

1.2

3.66

0.63

nmol/l

0.50

263

472

Sleep disorders (combined)

1224

3963

2.05

107.66

1.3

1.73

1.22

nmol/l

0.26

1183

3816

Dizziness and giddiness

938

3498

2.20

104.49

1.3

1.69

1.29

nmol/l

0.16

899

3377

Other soft tissue disorders, not elsewhere classified

1109

3295

2.10

103.16

1.2

1.3

1.11

1.02

nmol/l

0.07

1070

3177

Sleep apnoea, including avohilmo

1183

3827

2.03

101.34

1.3

1.77

1.25

nmol/l

0.25

1142

3688

Symptoms and signs involving cognition, perception, emotional state and behaviour

1162

4070

2.02

100.57

1.3

1.14

1.19

nmol/l

0.03

1108

3930

Abdominal and pelvic pain

1171

2869

2.07

99.51

1.2

1.3

0.94

1.45

nmol/l

0.36

1120

2775

Pain in joint

693

1846

2.51

99.12

1.3

1.78

1.92

nmol/l

0.03

661

1787

Other headache syndromes

562

2158

2.64

97.85

1.3

2.04

1.20

nmol/l

0.23

545

2066

Symptoms and signs involving the digestive system and abdomen

1165

2869

2.05

96.77

1.3

0.94

1.45

nmol/l

0.36

1115

2775

Sleep apnoea

1116

3773

2.03

96.69

1.3

1.84

1.26

nmol/l

0.27

1079

3635

Pure hypercholesterolaemia

840

2511

2.27

96.46

1.3

0.62

1.34

nmol/l

0.85

810

2426

Examination and observation for other reasons

706

1748

2.48

96.19

1.3

0.58

2.23

nmol/l

1.12

684

1676

Atrial fibrillation and flutter

371

689

3.57

95.93

1.3

3.47

2.23

nmol/l

0.15

355

667

Paroxysmal tachycardia

281

596

4.06

94.37

1.3

1.2

4.33

2.48

nmol/l

0.18

266

578

Type 2 diabetes, wide definition

960

2993

2.11

91.99

1.3

2.35

1.28

nmol/l

0.40

929

2880

Tramadol

939

2887

2.11

89.65

1.3

1.49

1.58

nmol/l

0.03

901

2785

Codeine

1120

3107

2.00

88.90

1.3

0.76

1.50

nmol/l

0.77

1072

2994

Depression medications

296

348

4.32

88.63

1.3

0.53

3.78

nmol/l

0.49

281

334

Heart failure and antihypertensive medication

274

446

4.12

86.44

1.3

4.58

3.16

nmol/l

0.12

259

428

Pain in limb

904

3170

2.08

85.61

1.2

1.3

1.70

1.04

nmol/l

0.29

874

3054

Nausea and vomiting

347

1097

3.17

83.78

1.3

2.29

1.67

nmol/l

0.15

327

1058

Codeine or tramadol medication

1323

4019

1.84

82.42

1.3

0.73

1.51

nmol/l

1.00

1272

3871

Dorsalgia

1146

3242

1.93

82.29

1.3

0.59

1.52

nmol/l

1.20

1100

3128

Symptoms and signs involving the nervous and musculoskeletal systems

694

3184

2.21

80.97

1.3

0.60

1.56

nmol/l

1.22

666

3057

Persons encountering health services in other circumstances, wide

1372

3957

1.81

80.57

1.3

0.89

1.25

nmol/l

0.33

1320

3818

Other functional intestinal disorders

531

2066

2.48

80.42

1.3

2.18

2.06

nmol/l

0.02

504

1992

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

406

650

3.16

80.28

1.3

0.58

2.16

nmol/l

0.49

390

629

Neurological diseases

997

2500

2.02

80.19

1.2

1.3

2.11

0.69

nmol/l

0.62

969

2390

Opioids

1139

3142

1.92

79.78

1.3

0.59

1.49

nmol/l

1.11

1093

3028

Other CVD (FINNGEN)

151

203

6.00

76.95

1.4

1.2

0.62

0.63

nmol/l

0.04

141

195

Syncope and collapse

495

1758

2.53

76.89

1.3

0.59

2.33

nmol/l

1.22

474

1685

Atrial fibrillation and flutter with reimbursement

296

538

3.58

76.60

1.3

4.21

2.70

nmol/l

0.15

283

523

Parasetamol

899

2250

2.06

75.69

1.2

1.3

1.72

1.37

nmol/l

0.11

862

2179

Migraine

578

2125

2.34

75.42

1.2

1.3

1.96

0.69

nmol/l

0.42

560

2038

Gastro-oesophageal reflux disease

783

3413

2.05

74.44

1.3

0.58

1.19

nmol/l

1.05

756

3294

Low back pain

825

3158

2.03

74.16

1.3

1.59

1.54

nmol/l

0.02

791

3046

Benzodiazepine use

1127

4425

1.83

72.97

1.3

1.73

1.18

nmol/l

0.27

1083

4262

Other nutritional deficiencies

759

3663

2.05

72.79

1.2

1.3

1.11

1.30

nmol/l

0.10

730

3524

Diabetes, varying definitions

1156

3804

1.83

72.49

1.3

2.05

1.11

nmol/l

0.44

1117

3667

Pain, not elsewhere classified

339

1175

2.93

72.08

1.3

3.01

3.00

nmol/l

0.00

327

1131

Neurological diseases, wide definition

352

553

3.23

71.86

1.2

1.3

0.55

0.57

nmol/l

0.33

341

530

Spondylopathies

901

2787

1.98

71.80

1.3

0.61

1.68

nmol/l

1.20

860

2692

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

453

1826

2.53

71.67

1.5

1.3

0.60

1.48

nmol/l

0.73

438

1752

Diabetes mellitus

1157

3818

1.82

71.60

1.3

2.05

1.11

nmol/l

0.44

1118

3679

Type 2 diabetes

1112

3616

1.84

70.92

1.3

2.12

1.15

nmol/l

0.43

1075

3486

Diverticular disease of intestine

784

2574

2.04

69.37

1.3

0.64

1.79

nmol/l

1.18

754

2490

Disorders of thyroid, IBD co-morbidities

219

405

4.00

69.09

1.2

0.58

0.60

nmol/l

0.20

210

388

General examination and investigation of persons without complaint and reported diagnosis

708

1757

2.16

68.66

1.3

0.59

2.22

nmol/l

1.11

690

1685

Condition for Implicit Sepsis (Organ dysfunction codes)

954

3709

1.89

68.41

1.3

1.95

1.29

nmol/l

0.27

910

3581

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1075

4279

1.82

68.30

1.3

0.64

1.49

nmol/l

1.35

1025

4135

Type 2 diabetes, definitions combined, including avohilmo

1068

3463

1.84

68.07

1.3

1.22

1.18

nmol/l

0.03

1033

3335

Fever of other and unknown origin

553

2296

2.25

67.53

1.3

0.62

1.91

nmol/l

1.17

535

2204

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1214

3947

1.77

67.15

1.3

1.60

1.25

nmol/l

0.16

1175

3810

Type 2 diabetes, definitions combined

1057

3463

1.84

67.01

1.3

1.23

1.18

nmol/l

0.03

1022

3340

Type 2 diabetes, strict (exclude DM1)

1062

3490

1.83

66.78

1.3

1.23

1.17

nmol/l

0.03

1026

3361

Lower back pain or/and sciatica

1131

4463

1.77

65.87

1.3

1.33

1.27

nmol/l

0.03

1084

4303

Anxiety disorders, excluding more controls

953

3403

1.87

65.75

1.3

1.88

1.35

nmol/l

0.21

915

3286

Implicit Sepsis

812

3297

1.93

63.62

1.3

1.68

1.52

nmol/l

0.05

773

3172

Irritable bowel syndrome

359

1372

2.66

63.45

1.2

1.3

2.87

1.73

nmol/l

0.19

347

1331

Obesity

710

3573

1.99

63.09

1.2

1.3

1.15

1.32

nmol/l

0.09

683

3433

Obesity and other hyperalimentation

712

3585

1.99

63.03

1.2

1.3

1.15

1.32

nmol/l

0.09

685

3445

Other symptoms and signs involving the nervous and musculoskeletal systems

507

2277

2.26

62.64

1.3

0.61

1.84

nmol/l

1.09

490

2194

Hyperlipidaemia, other/unspecified

419

1639

2.45

62.03

1.3

5.13

1.74

nmol/l

0.52

403

1573

First line medication for Crohn's disease

1215

3857

1.73

62.02

1.3

0.60

1.37

nmol/l

1.18

1161

3730

Mood disorders, excluding more controls

1048

3589

1.79

61.60

1.3

1.01

1.31

nmol/l

0.22

1007

3468

Other dorsopathies, not elsewhere classified

1088

3251

1.78

60.49

1.3

0.59

1.51

nmol/l

1.20

1044

3137

Other antidepressants

1121

3342

1.76

60.35

1.3

0.99

1.37

nmol/l

0.28

1074

3223

Obesity due to excess calories

550

2593

2.15

60.20

1.2

1.3

1.31

1.51

nmol/l

0.08

532

2498

Asthma, excluding more controls

845

2377

1.91

58.89

1.2

1.3

0.78

0.85

nmol/l

0.10

807

2298

Anxiety disorders

1012

4092

1.77

58.74

1.3

1.80

1.18

nmol/l

0.27

973

3943

Neurotic, stress-related and somatoform disorders

1002

4059

1.77

58.44

1.3

1.81

1.19

nmol/l

0.27

964

3910

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1035

3606

1.77

58.21

1.3

2.22

1.15

nmol/l

0.45

1002

3479

Pain (limb, back, neck, head abdominally)

753

1912

1.99

57.87

1.2

1.3

0.58

1.87

nmol/l

0.96

722

1852

Heart failure, not strict

827

3074

1.87

57.52

1.3

2.14

1.46

nmol/l

0.21

791

2966

Depression or dysthymia

783

2282

1.94

57.48

1.3

0.62

1.73

nmol/l

0.98

756

2203

Functional dyspepsia

343

1347

2.59

57.44

1.3

1.2

3.02

1.77

nmol/l

0.20

327

1299

Asthma, unspecified (mode), excluding more controls

574

2160

2.11

57.34

1.3

2.36

0.88

nmol/l

0.48

547

2089

Disorders of parathyroid gland

278

971

2.89

57.07

1.3

1.2

1.23

2.28

nmol/l

0.34

265

923

Gastrointestinal diseases

641

1543

2.10

56.79

1.2

1.3

0.56

1.57

nmol/l

0.74

619

1491

Used for control exclusion in common control thyroid runs

1115

3276

1.74

56.77

1.3

2.90

0.66

nmol/l

0.93

1077

3156

Symptoms and signs concerning food and fluid intake

148

352

4.31

56.48

1.3

0.61

0.66

nmol/l

0.91

140

339

Other specific joint derangements/joint disorders

808

2911

1.88

56.39

1.3

1.09

1.06

nmol/l

0.02

771

2802

Asthma

866

2511

1.86

56.26

1.2

1.3

0.77

1.25

nmol/l

0.49

826

2426

Dorsopathies

1101

3266

1.73

55.63

1.3

0.58

1.51

nmol/l

1.22

1061

3151

Hyperparathyroidism

249

833

3.02

55.42

1.3

1.2

1.31

2.55

nmol/l

0.35

237

791

ILD medications: prednisolone, methylprednisolone, prednisone

1182

3997

1.68

55.08

1.3

0.60

1.34

nmol/l

1.18

1128

3855

Spondylosis

581

2453

2.05

55.08

1.2

1.3

2.06

1.85

nmol/l

0.05

551

2366

Other special examinations and investigations of persons without complaint or reported diagnosis

691

1758

2.00

54.52

1.3

0.57

2.21

nmol/l

1.13

662

1686

Complications of surgical and medical care, not elsewhere classified

1037

4368

1.71

54.47

1.3

1.40

1.29

nmol/l

0.05

997

4208

Diabetes medication

1100

3964

1.70

53.96

1.3

2.12

1.09

nmol/l

0.46

1064

3820

Other intervertebral disc disorders

881

3007

1.81

53.59

1.3

0.60

1.60

nmol/l

1.21

848

2903

Mood [affective] disorders

1111

4384

1.68

53.05

1.3

0.98

1.37

nmol/l

0.32

1068

4232

Oral corticosteroids

1136

4130

1.68

52.98

1.3

0.60

1.32

nmol/l

1.19

1086

3986

Mood disorders

1112

4390

1.68

52.71

1.3

0.98

1.37

nmol/l

0.32

1069

4238

Exclusions for E4_PCOS_CONSORTIUM

822

2833

1.83

52.69

1.5

1.2

0.82

1.43

nmol/l

0.57

790

2733

Diabetes, insulin treatment (Kela reimbursement)

1073

3895

1.70

52.56

1.3

2.17

1.11

nmol/l

0.47

1038

3752

Asthma (only as main-diagnosis), excluding more controls

750

2377

1.89

52.54

1.3

0.79

0.85

nmol/l

0.07

715

2298

Asthma, unspecified (mode)

578

2282

2.03

52.23

1.3

2.35

1.33

nmol/l

0.29

551

2205

Depression

1043

4268

1.69

52.08

1.3

1.00

1.39

nmol/l

0.30

1002

4118

Other (not insulin) diabetes medications

1027

3645

1.71

51.67

1.3

1.23

1.15

nmol/l

0.05

994

3511

STROKE

635

2269

1.96

50.84

1.3

0.61

1.46

nmol/l

0.93

612

2195

Chronic kidney disease

304

1189

2.58

50.79

1.4

1.3

0.75

2.63

nmol/l

0.82

284

1142

Disorders of gallbladder, biliary tract and pancreas

1030

3957

1.69

50.20

1.3

0.61

1.37

nmol/l

1.18

989

3814

Asthma (mode)

833

2542

1.81

50.00

1.2

1.3

0.78

1.25

nmol/l

0.47

796

2457

Inflammatory bowel disease treatment related agents

1203

4223

1.63

49.66

1.3

0.60

1.30

nmol/l

1.18

1149

4074

Oedema, not elsewhere classified

320

1295

2.49

49.64

1.3

0.62

2.77

nmol/l

1.08

310

1248

Persons encountering health services in other circumstances

428

1976

2.19

49.41

1.2

1.3

0.58

1.82

nmol/l

0.93

409

1898

Biguanides

1001

3657

1.70

49.37

1.3

1.25

1.43

nmol/l

0.11

970

3522

Any mental disorder

1185

3639

1.64

48.97

1.3

0.98

1.30

nmol/l

0.25

1130

3514

Renal tubulo-interstitial diseases

893

3996

1.73

48.70

1.3

1.60

1.34

nmol/l

0.09

850

3853

Persons encountering health services for specific procedures and health care

1130

4303

1.64

48.53

1.3

0.61

1.25

nmol/l

1.05

1083

4149

Sciatica+with lumbago

542

2605

1.99

48.48

1.2

1.3

0.60

1.76

nmol/l

1.20

524

2509

Asthma (only as main-diagnosis)

758

2511

1.83

48.36

1.3

1.90

1.25

nmol/l

0.22

722

2426

Anxiety (asthma-related co-morbidities)

653

2748

1.89

48.23

1.3

1.19

1.44

nmol/l

0.11

628

2654

ILD medications

1188

4043

1.62

48.05

1.3

0.60

1.33

nmol/l

1.17

1138

3900

Hypo-osmolality and hyponatraemia

201

655

3.12

47.67

1.2

1.3

0.65

0.66

nmol/l

0.10

188

628

Migraine without aura

240

873

2.79

46.88

1.3

1.2

0.51

0.56

nmol/l

1.87

231

846

Psychiatric diseases

1159

3587

1.63

46.51

1.3

0.97

1.31

nmol/l

0.26

1105

3465

Somatoform disorder

227

813

2.85

45.81

1.3

0.56

1.99

nmol/l

0.52

213

790

Complications of procedures, not elsewhere classified

833

4218

1.72

45.76

1.3

1.59

1.32

nmol/l

0.10

801

4065

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

656

3345

1.83

45.36

1.3

1.89

1.53

nmol/l

0.10

630

3216

Dysphagia

260

1005

2.62

45.07

1.3

0.62

2.83

nmol/l

0.82

244

967

Recurrent or chronic depression

449

1548

2.12

44.73

1.3

0.58

2.14

nmol/l

0.92

429

1498

All anxiety disorders

657

2905

1.84

44.55

1.3

1.19

1.40

nmol/l

0.10

632

2810

Renal failure

422

1836

2.12

44.45

1.3

0.73

2.16

nmol/l

0.98

395

1761

Soft tissue disorders

1052

3341

1.64

44.44

1.2

1.3

1.96

1.01

nmol/l

0.40

1010

3220

Constipation

888

3791

1.69

44.32

1.3

0.64

1.40

nmol/l

1.12

849

3657

Statin medication

742

2323

1.80

44.19

1.2

1.3

0.86

1.44

nmol/l

0.42

717

2258

Symptoms and signs involving the skin and subcutaneous tissue

717

4082

1.76

43.96

1.3

1.75

1.34

nmol/l

0.13

696

3926

Disorders of mineral metabolism

122

305

4.12

43.83

1.2

1.3

0.66

0.64

nmol/l

0.27

116

294

Disorders of the thyroid gland

963

3828

1.65

43.71

1.3

2.26

1.18

nmol/l

0.42

928

3679

Benign neoplasm of colon, rectum, anus and anal canal

562

2098

1.93

43.51

1.4

1.2

2.14

1.96

nmol/l

0.04

534

2022

Any reimbursement code in KELA

604

1573

1.94

43.47

1.3

0.91

0.53

nmol/l

0.56

581

1528

Intracranial trauma

543

2104

1.94

43.28

1.2

1.3

0.57

0.71

nmol/l

0.79

529

2015

Concussion

471

2038

2.02

42.92

1.2

1.3

0.57

0.71

nmol/l

0.80

460

1952

Chronic lower respiratory diseases

1237

4303

1.56

42.86

1.3

0.73

1.25

nmol/l

0.71

1183

4154

Disturbances of skin sensation

328

1445

2.30

42.75

1.3

3.06

1.66

nmol/l

0.22

320

1399

Other/unspecified dorsalgia

396

1876

2.12

42.36

1.3

2.70

2.12

nmol/l

0.10

377

1801

Hernia of abdominal wall, postoperative

181

607

3.03

41.09

1.4

1.2

0.66

5.17

nmol/l

1.06

175

586

Asthma (diagnoses ohter than nonallergic)

869

4548

1.64

40.47

1.2

1.3

1.74

1.22

nmol/l

0.21

827

4386

Continuous positive airway pressure

192

573

2.93

39.80

1.2

1.3

0.57

2.61

nmol/l

0.51

177

553

Disorder of lipoprotein metabolism, unspecified

157

496

3.23

39.59

1.4

1.3

1.77

0.66

nmol/l

0.50

145

477

Migraine with aura

262

1088

2.44

39.07

1.2

1.3

0.53

0.57

nmol/l

1.56

253

1048

Spinal stenosis

499

2055

1.92

38.79

1.2

1.3

2.32

2.10

nmol/l

0.04

475

1975

Nerve, nerve root and plexus disorders

1064

4290

1.57

38.50

1.2

1.3

1.58

1.26

nmol/l

0.12

1031

4124

Vocal cord dysfunction

149

427

3.29

38.27

1.4

1.2

0.61

0.59

nmol/l

0.22

143

413

Lumbar disc prolapse

638

2890

1.77

38.25

1.3

0.59

1.64

nmol/l

1.22

618

2790

Follow-up examination after treatment for conditions other than malignant neoplasms

437

1430

2.02

37.76

1.3

0.60

2.60

nmol/l

1.11

428

1363

Excluding asthma or asthma-COPD overlap

841

2534

1.67

37.62

1.2

1.3

1.95

1.25

nmol/l

0.21

809

2449

Hypothyroidism, other/unspecified

882

3612

1.62

37.20

1.3

2.42

1.22

nmol/l

0.43

851

3469

Persons encountering health services for examination and investigation

631

1758

1.81

37.15

1.3

0.60

2.21

nmol/l

1.10

609

1686

Ischaemic heart disease, wide definition

784

2949

1.68

37.11

1.3

1.97

1.28

nmol/l

0.21

751

2843

Other pulmonary diagnosis

838

2534

1.67

36.99

1.2

1.3

1.96

1.25

nmol/l

0.21

804

2449

Obesity related asthma

373

1836

2.06

36.72

1.2

1.3

3.27

2.14

nmol/l

0.19

356

1775

Endocrine disorders, other/unspecified

8.39

36.61

2.1

1.2

0.60

0.51

nmol/l

1.24

Cholelithiasis

832

3597

1.63

36.45

1.3

0.61

1.45

nmol/l

1.21

804

3467

Abnormal weight loss

129

382

3.47

36.30

1.2

1.3

0.62

0.66

nmol/l

0.64

122

364

Ischemic heart diseases

788

2991

1.66

36.14

1.3

1.96

1.27

nmol/l

0.21

757

2882

Cholelithiasis, broad definition with cholecystitis

857

3655

1.62

35.99

1.3

0.61

1.44

nmol/l

1.20

829

3522

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

141

444

3.24

35.84

1.5

1.3

0.69

2.96

nmol/l

0.48

136

430

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

132

400

3.38

35.75

1.6

1.3

0.68

0.65

nmol/l

0.56

127

387

Disorders of calcium metabolism

226

4.29

35.69

1.2

1.3

0.66

0.65

nmol/l

0.06

217

Abnormal findings on examination of blood, without diagnosis

437

2144

1.93

35.39

1.3

0.64

2.02

nmol/l

1.17

416

2062

COPD differential diagnosis

831

2542

1.65

35.13

1.3

1.96

1.25

nmol/l

0.21

799

2457

ILD differential diagnosis

831

2542

1.65

35.13

1.3

1.96

1.25

nmol/l

0.21

799

2457

Autoimmune diseases excluding thyroid diseases, strict definition

975

3481

1.57

34.70

1.3

1.78

0.66

nmol/l

0.47

939

3351

Infections, IBD-co-morbidities

150

346

3.19

34.54

1.3

1.2

0.58

0.62

nmol/l

0.42

141

333

Cough

368

1764

2.02

34.43

1.2

1.3

0.61

1.33

nmol/l

0.64

355

1698

Weight loss

134

420

3.27

34.42

1.2

1.3

0.62

0.65

nmol/l

0.40

127

402

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

351

1058

2.12

34.35

1.2

0.59

1.63

nmol/l

0.48

335

1026

Autoimmune diseases excluding thyroid diseases

1020

3675

1.55

34.27

1.3

1.72

0.66

nmol/l

0.47

983

3539

Hypothyreosis and Thyroxine purchase for inclusion criteria

911

3838

1.58

34.17

1.3

2.35

1.19

nmol/l

0.44

880

3682

Hard cardiovascular diseases

785

3101

1.64

34.11

1.4

1.3

1.97

1.25

nmol/l

0.22

755

2990

Other anxiety disorders

460

2197

1.87

33.99

1.3

1.45

1.17

nmol/l

0.10

445

2126

Symptoms and signs involving the urinary system

744

3533

1.64

33.72

1.3

0.64

1.70

nmol/l

1.40

709

3402

Diarrhoea and gastroenteritis of presumed infectious origin

686

3781

1.66

33.54

1.3

1.79

1.39

nmol/l

0.12

660

3633

Benign neoplasm: Colon

471

1952

1.87

33.49

1.4

1.2

2.42

2.07

nmol/l

0.07

446

1881

Haemorrhage from respiratory passages

294

1264

2.18

33.42

1.3

0.66

1.65

nmol/l

0.62

276

1215

Benign neoplasm of other and ill-defined parts of digestive system

205

825

2.53

32.95

1.4

1.2

0.59

3.78

nmol/l

1.00

190

797

Autoimmune diseases

1093

3700

1.52

32.80

1.3

3.11

0.66

nmol/l

1.03

1054

3564

Cholecystectomy

693

3745

1.65

32.79

1.3

1.79

1.43

nmol/l

0.11

672

3597

Selective serotonin reuptake inhibitors

983

3357

1.55

32.78

1.3

1.02

1.36

nmol/l

0.23

941

3237

Shoulder lesions

749

2821

1.64

32.32

1.2

1.3

0.60

1.11

nmol/l

0.67

713

2723

Diaphragmatic hernia

378

1957

1.95

32.29

1.3

0.63

2.18

nmol/l

1.20

357

1871

Cervical disc disorders

371

1912

1.96

32.09

1.3

2.85

2.19

nmol/l

0.11

361

1841

Certain infectious and parasitic diseases

1008

3309

1.53

31.74

1.3

1.73

1.15

nmol/l

0.20

967

3195

Complications of medical and surgical care

707

4170

1.62

31.69

1.3

1.76

1.33

nmol/l

0.14

680

4016

Cystitis

830

3217

1.59

31.63

1.3

1.99

1.37

nmol/l

0.17

794

3103

Myalgia

249

1112

2.27

31.57

1.2

1.3

0.56

1.63

nmol/l

0.53

234

1071

Asthma-related infections

558

3219

1.72

31.46

1.3

2.09

1.48

nmol/l

0.15

529

3094

Asthma, hospital admission 2, infections

558

3219

1.72

31.46

1.3

2.09

1.48

nmol/l

0.15

529

3094

Other general symptoms and signs

145

4.90

31.44

1.3

0.52

0.62

nmol/l

1.13

140

Pain in thoracic spine

176

673

2.66

31.42

1.2

1.3

0.53

2.91

nmol/l

0.73

165

653

Other disorders of urethra and urinary system

674

3082

1.65

31.24

1.2

1.3

0.61

1.41

nmol/l

1.11

638

2972

439

2397

1.83

30.91

1.3

2.48

1.77

nmol/l

0.14

418

2307

Abnormal findings on diagnostic imaging of other body structures

166

623

2.72

30.87

1.4

1.3

5.56

2.48

nmol/l

0.25

161

597

Benign neoplasm of colon, rectum, anus and anal canal

581

3118

1.69

30.75

1.4

1.3

2.10

1.60

nmol/l

0.13

551

3000

Asthma, including avohilmo

1136

4497

1.47

30.72

1.2

1.3

0.73

1.23

nmol/l

0.71

1090

4334

Other CVD

191

774

2.50

30.22

1.4

1.3

0.61

0.67

nmol/l

1.07

180

739

Visual disturbances and blindness

495

2845

1.75

30.16

1.3

4.56

1.27

nmol/l

0.60

479

2725

Hypotension

166

630

2.68

30.09

1.4

1.3

0.62

0.69

nmol/l

1.04

155

601

Genitourinary diseases

578

1677

1.74

29.89

1.3

0.57

1.66

nmol/l

0.97

552

1633

1120

4028

1.48

29.78

1.3

2.37

1.06

nmol/l

0.51

1077

3884

COPD/asthma/ILD related infections

1063

3579

1.49

29.77

1.3

1.68

1.11

nmol/l

0.21

1015

3456

COPD/asthma related infections

1063

3579

1.49

29.77

1.3

1.68

1.11

nmol/l

0.21

1015

3456

Other disorders of kidney and ureter

155

573

2.76

29.69

1.5

1.3

0.76

0.64

nmol/l

0.58

144

551

Finngen Rheumatological endpoints

952

3592

1.52

29.57

1.3

1.03

1.26

nmol/l

0.15

916

3467

Cervicalgia

223

981

2.30

29.36

1.3

0.58

3.28

nmol/l

1.01

214

941

Aplastic and other anaemias

400

2060

1.86

29.22

1.3

0.68

2.00

nmol/l

1.03

377

1974

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

918

4144

1.51

29.02

1.4

1.3

1.73

1.07

nmol/l

0.24

889

3990

Diseases of the skin and subcutaneous tissue

1007

3381

1.50

28.81

1.3

0.58

1.48

nmol/l

1.22

958

3271

Other neurological diseases

678

3414

1.61

28.73

1.3

1.82

1.51

nmol/l

0.09

655

3274

Viral Sepsis

194

812

2.42

28.65

1.3

4.87

3.31

nmol/l

0.13

187

785

Other joint disorders

857

2968

1.55

28.46

1.2

1.3

1.05

nmol/l

0.00

830

2857

Visual disturbances

463

2659

1.76

28.35

1.3

4.83

1.32

nmol/l

0.60

448

2547

Bleeding

775

3639

1.56

28.33

1.3

0.62

1.67

nmol/l

1.44

740

3512

Implicit viral Sepsis

193

810

2.41

28.33

1.3

4.90

3.32

nmol/l

0.13

186

783

Benign neoplasm of other and ill-defined parts of digestive system

205

886

2.35

28.24

1.4

1.3

0.59

1.93

nmol/l

0.52

190

852

Insulin medication

541

2759

1.69

28.09

1.3

2.86

1.03

nmol/l

0.45

520

2649

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

867

3371

1.53

27.99

1.6

1.2

0.62

1.43

nmol/l

1.04

841

3250

Migraine without aura and triptan purchases

183

755

2.46

27.93

1.2

1.3

0.51

2.06

nmol/l

0.52

175

729

Asthma, hospital admissions , main diagnosis only

784

4593

1.54

27.88

1.3

1.85

1.22

nmol/l

0.24

748

4426

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

866

3371

1.53

27.80

1.6

1.2

0.62

1.43

nmol/l

1.04

840

3250

Malignant neoplasm, wide definition for exclusion

866

3373

1.53

27.73

1.6

1.2

0.62

1.42

nmol/l

1.04

840

3252

Diseases of inner ear

521

3054

1.68

27.31

1.3

2.22

1.62

nmol/l

0.14

499

2934

Malignant neoplasm of kidney, except renal pelvis

108

343

3.22

27.21

1.6

1.3

0.67

nmol/l

0.07

103

325

Use of hypnotics and sedatives

1024

4053

1.47

27.13

1.3

1.06

1.23

nmol/l

0.12

982

3913

Temporomandibular joint disorders

161

635

2.57

27.01

1.3

0.59

2.42

nmol/l

0.51

154

610

Intestinal infectious diseases

881

4609

1.49

26.96

1.3

1.52

1.25

nmol/l

0.10

849

4439

Disorders of vestibular function (Vertigo)

458

2645

1.73

26.85

1.3

2.43

1.68

nmol/l

0.16

439

2540

Other and unspecified anaemias

361

1897

1.86

26.53

1.3

0.69

2.12

nmol/l

1.03

341

1819

Malignant neoplasm of urinary organs

112

369

3.10

26.52

1.6

1.3

0.68

0.67

nmol/l

0.11

107

348

Disorders of eyelid, lacrimal system and orbit

791

4095

1.52

26.50

1.2

1.3

1.64

1.35

nmol/l

0.10

755

3942

Valvular heart disease excluding rheumatic fever

424

1746

1.79

26.26

1.4

1.3

5.07

1.49

nmol/l

0.58

409

1686

Obesity, other/unspecified

340

1823

1.88

26.22

1.2

1.3

0.57

1.78

nmol/l

0.82

325

1761

Subjective visual disturbances

259

1266

2.07

26.21

1.3

3.78

0.94

nmol/l

0.42

249

1220

Other anaemias

364

1920

1.84

26.20

1.3

0.69

2.10

nmol/l

1.03

344

1841

Diseases of the ear and mastoid process

1144

4056

1.43

26.08

1.3

0.58

1.33

nmol/l

1.23

1095

3909

Diseases of the musculoskeletal system and connective tissue

511

1491

1.73

26.06

1.3

0.54

1.49

nmol/l

0.65

489

1440

Insulin, intermediate and long-acting

502

2956

1.68

26.04

1.3

3.02

1.21

nmol/l

0.40

484

2840

Diseases of arteries, arterioles and capillaries

600

2781

1.62

26.03

1.3

3.81

1.34

nmol/l

0.55

569

2668

Other systemic involvement of connective tissue (FG)

273

1354

2.03

25.99

1.3

0.61

2.25

nmol/l

0.82

261

1298

Non-rheumatic valve diseases

421

1737

1.78

25.82

1.4

1.3

5.12

1.50

nmol/l

0.58

406

1677

Glucagon-like peptide-1 (GLP-1) analogues

498

2445

1.69

25.74

1.3

0.65

1.54

nmol/l

0.80

479

2346

Nutritional anaemias

437

2467

1.74

25.71

1.3

0.66

1.76

nmol/l

1.04

411

2369

Diseases of the digestive system

409

2327

1.77

25.69

1.3

0.61

1.92

nmol/l

1.21

387

2234

Paralytic ileus and intestinal obstruction

231

1089

2.14

25.65

1.3

4.21

3.19

nmol/l

0.10

225

1053

Other and unspecified iron deficiency

306

1603

1.93

25.34

1.4

1.3

0.66

2.23

nmol/l

0.94

291

1546

Other symptoms and signs involving the digestive system and abdomen

170

711

2.42

25.22

1.3

0.60

2.24

nmol/l

0.52

164

688

Systemic connective tissue disorders

353

1940

1.84

25.20

1.3

0.62

1.44

nmol/l

0.71

337

1854

Other and unspecified effects of external causes

277

1408

1.99

25.11

1.2

1.3

0.51

1.68

nmol/l

0.76

263

1363

Hypothyroidism, strict autoimmune

669

2833

1.57

25.09

1.3

3.01

0.69

nmol/l

0.77

643

2719

Exposure to unspecified factor

901

4793

1.47

25.00

1.3

1.53

1.22

nmol/l

0.12

864

4621

Endometriosis

372

1201

1.86

25.00

1.3

0.55

1.89

nmol/l

0.73

360

1153

Other bacterial diseases

875

4111

1.48

24.94

1.3

0.64

1.53

nmol/l

1.36

835

3975

Adverse effects, not elsewhere classified

212

979

2.19

24.92

1.2

1.3

0.51

1.75

nmol/l

0.55

200

949

Ovarian cyst

386

1226

1.84

24.82

1.2

1.3

0.58

1.87

nmol/l

0.71

370

1174

Autoimmune diseases related-to ILD

800

4738

1.49

24.81

1.3

1.64

1.23

nmol/l

0.15

774

4560

Dental pulpitis 4, only avohilmo

1052

3830

1.44

24.81

1.2

1.3

0.59

1.60

nmol/l

1.49

1011

3686

Acute upper respiratory infections

987

4290

1.45

24.80

1.3

2.59

1.04

nmol/l

0.55

953

4130

Other gastritis (incl. Duodenitis)

222

1048

2.14

24.65

1.2

1.3

0.64

2.13

nmol/l

0.70

215

1009

Other noninfective gastroenteritis and colitis

244

1193

2.07

24.61

1.3

0.62

1.91

nmol/l

0.69

232

1148

Dental pulpitis 1, only avohilmo

1054

3845

1.44

24.61

1.2

1.3

0.59

1.60

nmol/l

1.49

1012

3701

Benign neoplasm: Colon

476

2804

1.68

24.59

1.4

1.3

2.41

1.65

nmol/l

0.16

450

2691

Other diseases of urinary system

954

3692

1.46

24.58

1.3

1.80

1.33

nmol/l

0.15

911

3565

Personality disorders, excluding more controls

246

1211

2.05

24.39

1.2

1.3

2.26

1.65

nmol/l

0.12

236

1180

Rotator cuff syndrome

562

2595

1.62

24.32

1.2

1.3

0.60

1.16

nmol/l

0.68

535

2501

Urticaria and erythema

366

2056

1.80

24.30

1.2

1.3

0.55

1.35

nmol/l

0.75

358

1983

Dental pulpitis 1

1025

3717

1.44

24.04

1.2

1.3

0.59

1.63

nmol/l

1.46

987

3577

Abnormal involuntary movements

147

589

2.54

24.01

1.3

0.53

2.57

nmol/l

0.53

139

565

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

487

2904

1.65

23.95

1.3

0.57

1.63

nmol/l

1.24

468

2802

Dental pulpitis 4

1024

3716

1.44

23.90

1.2

1.3

0.59

1.63

nmol/l

1.46

986

3576

Care involving use of rehabilitation procedures

597

3623

1.57

23.90

1.3

1.99

1.39

nmol/l

0.17

577

3490

Nonorganic sleeping disorders, excluding more controls

181

800

2.29

23.68

1.2

1.3

0.57

1.98

nmol/l

0.49

175

779

Dermatitis and eczema

1012

4673

1.43

23.66

1.3

0.58

1.42

nmol/l

1.52

971

4505

Other diseases of upper respiratory tract

1047

3838

1.43

23.66

1.2

1.3

0.61

1.38

nmol/l

1.17

1001

3692

151

617

2.48

23.64

1.5

1.3

3.39

2.45

nmol/l

0.11

142

594

Non-selective monoamine reuptake inhibitors

381

2115

1.76

23.62

1.3

1.75

1.76

nmol/l

0.00

370

2035

Polyuria

206

965

2.16

23.36

1.3

0.60

1.90

nmol/l

0.63

192

928

Chronic gastritis

261

1336

1.97

23.23

1.3

4.69

1.96

nmol/l

0.29

244

1276

Other reaction to severe stress, and adjustment disorders

351

1978

1.79

23.07

1.3

1.2

2.86

1.24

nmol/l

0.30

345

1920

Infections of the skin and subcutaneous tissue

524

3271

1.61

22.99

1.3

0.57

1.51

nmol/l

1.23

502

3150

Diseases of pulp and periapical tissues, including avohilmo

1017

3715

1.43

22.94

1.2

1.3

0.59

1.63

nmol/l

1.46

980

3575

Urticaria

300

1620

1.87

22.72

1.2

1.3

0.54

1.54

nmol/l

0.74

293

1566

Oxycodone

311

1647

1.84

22.38

1.3

3.32

2.37

nmol/l

0.13

296

1577

Fall on same level

1089

4362

1.40

22.36

1.3

0.80

1.23

nmol/l

0.53

1047

4209

Osteopathies and chondropathies

515

3068

1.60

22.30

1.3

2.24

1.54

nmol/l

0.17

499

2944

Disorders of conjunctiva

761

4338

1.48

22.25

1.3

0.58

1.47

nmol/l

1.49

732

4174

Diseases of the eye and adnexa

788

2657

1.49

22.12

1.2

1.3

3.31

0.82

nmol/l

0.69

765

2565

Cerebrovascular diseases

665

3144

1.52

22.12

1.4

1.3

1.89

1.59

nmol/l

0.08

632

3026

Insulin, combination of fast acting with intermediate-acting or long-acting

541

3172

1.58

22.09

1.3

2.86

1.17

nmol/l

0.40

520

3049

Enthesopathies of lower limb, excluding foot

218

1068

2.06

22.00

1.2

1.3

4.40

3.23

nmol/l

0.11

208

1030

Other systemic involvement of connective tissue

278

1484

1.89

21.88

1.3

0.60

1.68

nmol/l

0.72

266

1424

Implicit bacterial Sepsis

332

1709

1.79

21.82

1.3

3.25

2.27

nmol/l

0.14

313

1639

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

241

1228

1.98

21.81

1.3

1.25

2.39

nmol/l

0.37

233

1183

Iron deficiency anaemia

371

2139

1.73

21.75

1.3

0.66

1.93

nmol/l

1.03

349

2058

Convulsions, not elsewhere classified

194

901

2.14

21.71

1.3

0.59

3.71

nmol/l

1.09

184

867

Adjustment and management of implanted device

167

743

2.27

21.57

1.3

0.64

2.08

nmol/l

0.53

159

721

Gingivitis and periodontal diseases

850

3021

1.46

21.51

1.3

0.63

1.11

nmol/l

0.66

816

2917

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

551

3538

1.56

21.49

1.3

2.10

1.47

nmol/l

0.16

532

3401

Noninfective enteritis and colitis

432

2626

1.65

21.46

1.3

0.61

1.66

nmol/l

1.07

415

2534

Acute upper respiratory infections of multiple and unspecified sites

680

3407

1.50

21.38

1.2

1.3

3.46

1.09

nmol/l

0.59

654

3280

Substance abuse, excluding more controls

471

2553

1.62

21.33

1.2

1.3

0.63

1.58

nmol/l

0.93

450

2475

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

324

2.99

21.28

1.2

0.54

0.51

nmol/l

0.72

318

Falls/tendency to fall

1062

3823

1.40

21.04

1.3

1.16

1.21

nmol/l

0.03

1016

3694

Polyarthropathies

606

2633

1.54

21.04

1.2

1.3

2.36

1.12

nmol/l

0.31

572

2529

Dentinal caries

214

1054

2.04

20.98

1.3

0.59

1.86

nmol/l

0.61

208

1018

Panic disorder

153

664

2.33

20.97

1.3

3.26

0.55

nmol/l

0.49

146

644

Chronic pancreatitis

133

543

2.49

20.95

1.5

1.3

0.61

0.62

nmol/l

0.16

123

519

Factors influencing health status and contact with health services

272

698

1.97

20.87

1.3

0.60

2.54

nmol/l

0.62

263

675

Hernia

871

4155

1.43

20.77

1.3

0.62

1.52

nmol/l

1.39

833

4009

Coronary atherosclerosis

615

2602

1.53

20.66

1.3

2.36

1.38

nmol/l

0.24

584

2502

Major coronary heart disease event excluding revascularizations

585

2629

1.55

20.62

1.4

1.3

2.44

1.39

nmol/l

0.24

560

2515

Benign paroxysmal vertigo

279

1522

1.85

20.55

1.3

3.59

2.36

nmol/l

0.16

269

1458

Care involving dialysis

311

2.98

20.33

1.4

1.3

0.68

0.66

nmol/l

0.19

302

Dialysis, with operation codes

131

539

2.47

20.30

1.3

0.81

0.62

nmol/l

0.87

123

517

Diseases of oral cavity, salivary glands and jaws

847

3025

1.44

20.22

1.3

2.33

1.11

nmol/l

0.43

819

2920

Any event in cancer register

865

3614

1.43

19.98

1.6

1.2

0.61

1.37

nmol/l

1.06

832

3494

Hypermobility syndrome

203

3.48

19.79

1.2

1.3

0.52

0.54

nmol/l

0.26

197

Disorders of synovium and tendon

474

2704

1.59

19.72

1.2

1.3

2.74

1.12

nmol/l

0.34

463

2604

COPD (mode)

277

1197

1.85

19.71

1.3

0.70

1.86

nmol/l

0.66

263

1146

Asthma/COPD (KELA code 203)

857

4287

1.41

19.56

1.3

0.79

1.25

nmol/l

0.56

815

4138

814

3576

1.43

19.51

1.3

1.68

1.11

nmol/l

0.22

759

3453

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

814

3576

1.43

19.51

1.3

1.68

1.11

nmol/l

0.22

759

3453

Other or unspecified ileus, impaction or obstruction

160

730

2.21

19.45

1.3

5.85

4.17

nmol/l

0.12

154

706

Diseases of the respiratory system

626

2070

1.52

19.42

1.2

1.3

2.42

1.40

nmol/l

0.23

602

1999

Cervicobrachial syndrome

215

1098

1.98

19.38

1.3

0.54

2.97

nmol/l

1.03

209

1061

External causes of morbidity and mortality

653

2183

1.51

19.24

1.3

3.00

1.16

nmol/l

0.46

620

2115

Conjunctivitis

687

4120

1.46

19.22

1.3

0.57

1.48

nmol/l

1.41

662

3963

Behavioural syndromes associated with physiological disturbances and physical factors

292

1652

1.78

19.02

1.3

0.56

1.50

nmol/l

0.70

279

1597

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

509

3322

1.54

18.82

1.3

0.60

1.53

nmol/l

1.24

490

3187

Dental caries

235

1236

1.90

18.82

1.4

1.3

0.59

1.68

nmol/l

0.61

228

1193

Other and unspecified dermatitis

464

2973

1.57

18.71

1.3

0.58

1.62

nmol/l

1.24

445

2862

Heart failure,strict

446

2020

1.60

18.64

1.3

3.16

1.83

nmol/l

0.22

418

1936

GI-bleeding

260

1432

1.83

18.56

1.3

0.64

2.58

nmol/l

1.08

245

1380

Bronchitis

964

4611

1.38

18.53

1.2

1.3

2.64

1.00

nmol/l

0.56

921

4445

Other enthesopathies

280

1582

1.78

18.39

1.2

1.3

0.58

1.48

nmol/l

0.66

275

1521

Benign neoplasm: Pancreas

4.71

18.39

1.7

1.3

0.56

0.62

nmol/l

0.76

Glomerular disorders in diseases classified elsewhere

117

480

2.47

18.30

1.2

1.3

0.74

0.62

nmol/l

0.37

108

458

Other diseases of the digestive system

262

1454

1.82

18.27

1.3

0.63

2.55

nmol/l

1.09

246

1401

Coxibs

240

661

1.94

18.21

1.3

0.59

1.63

nmol/l

0.85

229

635

Polycystic ovarian syndrome, consortium definition

683

2830

1.46

18.21

1.3

0.59

1.15

nmol/l

0.73

656

2719

Dentofacial anomalies [including malocclusion]

261

1433

1.82

18.17

1.4

1.2

0.56

1.51

nmol/l

0.62

251

1381

Myocardial infarction, without ST-elevation

310

1668

1.73

17.98

1.3

4.12

1.71

nmol/l

0.31

295

1590

Abnormal findings on diagnostic imaging of lung

396

2405

1.61

17.87

1.3

0.63

1.90

nmol/l

1.21

379

2300

Major coronary heart disease event

624

2832

1.48

17.82

1.4

1.3

2.33

1.62

nmol/l

0.16

598

2716

Nephropathy related operations

124

529

2.38

17.80

1.3

0.80

0.64

nmol/l

0.62

117

507

Gonarthrosis [arthrosis of knee](FG)

691

2810

1.45

17.78

1.2

1.3

1.45

1.48

nmol/l

0.01

667

2708

COPD

372

1876

1.65

17.73

1.3

2.97

2.05

nmol/l

0.15

351

1794

Intestinal stricture

269

1520

1.78

17.70

1.3

3.72

2.35

nmol/l

0.17

261

1460

Dermatitis

541

3627

1.50

17.69

1.3

0.58

1.67

nmol/l

1.52

521

3494

Glomerular diseases

170

826

2.08

17.69

1.2

1.3

0.70

1.89

nmol/l

0.46

157

794

Gonarthrosis

590

2267

1.50

17.66

1.2

1.3

1.60

1.23

nmol/l

0.16

570

2180

Tinnitus

230

1241

1.87

17.64

1.3

0.58

2.72

nmol/l

1.02

223

1200

Generalized anxiety disorder

147

677

2.20

17.55

1.3

3.35

2.22

nmol/l

0.14

142

659

Other external causes of accidental injury

801

2839

1.42

17.51

1.3

1.11

1.43

nmol/l

0.17

768

2751

Arthropathies

821

2972

1.41

17.48

1.3

1.82

1.05

nmol/l

0.25

792

2860

Bacterial Sepsis

362

1969

1.65

17.48

1.3

3.03

2.15

nmol/l

0.14

342

1888

Acute sinusitis

472

2871

1.54

17.39

1.3

2.37

1.17

nmol/l

0.29

450

2769

Malignant neoplasm

820

3486

1.40

17.27

1.6

1.2

0.61

1.40

nmol/l

1.07

792

3365

Adenomyosis (Endometriosis of uterus)

150

705

2.16

17.08

1.3

0.58

2.86

nmol/l

0.72

145

673

Covid-19 confirmed case

248

1386

1.80

16.95

1.2

1.3

0.60

0.90

nmol/l

0.51

242

1332

Accidents

796

2839

1.41

16.82

1.3

1.12

1.43

nmol/l

0.17

763

2751

Sleep disorders

206

1090

1.91

16.81

1.2

1.3

0.57

1.62

nmol/l

0.50

198

1055

Pacemaker

251

1370

1.79

16.80

1.3

0.73

1.57

nmol/l

0.55

237

1302

Other diseases of intestine

113

475

2.41

16.78

1.5

1.3

0.66

3.04

nmol/l

0.49

107

456

Other disorders of teeth and supporting structures

197

1028

1.93

16.76

1.3

2.80

1.93

nmol/l

0.14

188

987

Noninfectious colitis NAS

133

604

2.23

16.50

1.3

0.61

0.62

nmol/l

0.12

123

580

Soft tissue disorders related to use, overuse and pressure

240

1341

1.80

16.45

1.3

4.11

1.66

nmol/l

0.30

229

1279

Myocardial infarction

432

1992

1.57

16.44

1.4

1.3

3.09

1.62

nmol/l

0.26

414

1901

Disorders of lacrimal system

376

2369

1.60

16.41

1.3

0.57

1.74

nmol/l

1.08

361

2276

Diseases of pulp and periapical tissues

309

1855

1.68

16.36

1.2

1.3

0.59

1.42

nmol/l

0.73

300

1792

Chronic rhinitis, nasopharyngitis and pharyngitis

293

1737

1.70

16.29

1.2

1.3

0.58

2.22

nmol/l

1.11

277

1674

Injuries to the knee and lower leg

1062

4577

1.33

16.28

1.2

1.3

0.58

1.44

nmol/l

1.50

1034

4396

Inflammatory diseases of female pelvic organs

575

2968

1.47

16.27

1.2

1.3

0.56

1.41

nmol/l

1.06

551

2857

Nonorganic sleeping disorders

181

928

1.97

16.25

1.2

1.3

0.57

1.80

nmol/l

0.50

175

895

Benign neoplasm: Pancreas

105

4.26

16.24

1.7

1.2

0.56

0.62

nmol/l

0.85

Disorders of vitreous body

433

2763

1.54

16.21

1.2

1.3

0.59

1.96

nmol/l

1.42

415

2649

Angina pectoris

524

2372

1.50

16.21

1.3

4.26

1.46

nmol/l

0.55

503

2275

Acute renal failure

168

840

2.02

16.19

1.3

0.69

1.88

nmol/l

0.48

159

808

Other disorders of lacrimal gland

313

1893

1.67

16.15

1.2

1.3

0.57

2.01

nmol/l

1.06

304

1816

Influenza and pneumonia

942

4605

1.35

16.12

1.3

1.53

1.23

nmol/l

0.12

887

4458

Other chronic obstructive pulmonary disease, including avohilmo

439

2378

1.54

16.10

1.2

1.3

2.62

1.90

nmol/l

0.14

417

2276

Other diseases of pancreas

314

2.73

16.00

1.3

0.63

nmol/l

0.08

297

Disorders of vitreous body and globe

442

2831

1.53

15.99

1.2

1.3

0.59

1.93

nmol/l

1.43

424

2717

Cervicocranial syndrome

108

456

2.40

15.91

1.2

1.3

0.58

3.10

nmol/l

0.51

103

442

Migraine, single triptan purchase ok & required. ICD-code if available is included

723

3501

1.40

15.84

1.3

1.68

1.39

nmol/l

0.09

706

3371

Triptan medication for migraine, single purchase ok

723

3501

1.40

15.84

1.3

1.68

1.39

nmol/l

0.09

706

3371

Urolithiasis

267

1556

1.73

15.82

1.2

1.3

0.65

2.55

nmol/l

1.16

260

1495

Parodontitis or operation codes

801

4305

1.38

15.78

1.3

0.65

1.49

nmol/l

1.34

767

4150

Cutaneous abscess, furuncle and carbuncle

232

1304

1.79

15.62

1.3

0.56

2.41

nmol/l

0.92

222

1259

Acetic acid derivatives and related substances

232

654

1.86

15.42

1.2

1.3

0.59

1.64

nmol/l

0.86

221

628

Algoneurodystrophy

141

3.65

15.42

1.2

1.4

0.57

0.60

nmol/l

0.23

135

Epilepsy

241

1372

1.76

15.34

1.3

5.30

1.55

nmol/l

0.36

233

1315

Hypothyroidism, strict autoimmune, 3 medication purchases required

732

3602

1.39

15.27

1.3

2.81

1.23

nmol/l

0.49

702

3452

Acute tubulo-interstitial nephritis

511

3088

1.47

15.24

1.3

2.27

1.51

nmol/l

0.18

485

2966

Aortic aneurysm

166

829

1.98

15.23

1.2

1.3

0.63

0.88

nmol/l

0.64

157

795

Parodontitis

797

4309

1.37

15.23

1.3

0.65

1.49

nmol/l

1.34

763

4154

Provisional assignment of new diseases of uncertain etiology

377

2420

1.57

15.19

1.2

1.3

4.10

1.19

nmol/l

0.46

368

2327

Codes for special purposes

378

2428

1.57

15.18

1.2

1.3

4.09

1.19

nmol/l

0.46

369

2334

Thyrotoxicosis, other and/or unspecified

190

1014

1.89

15.17

1.2

1.3

0.62

1.75

nmol/l

0.50

179

976

Chronic periodontitis, including avohilmo

794

4312

1.37

15.12

1.3

0.64

1.49

nmol/l

1.34

760

4157

Other chronic obstructive pulmonary disease

348

1814

1.60

15.10

1.3

3.13

2.10

nmol/l

0.16

328

1733

Gastroduodenal ulcer

202

1097

1.85

15.09

1.3

0.63

2.25

nmol/l

0.83

197

1051

Disorders of skin appendages

420

2764

1.53

15.09

1.2

1.3

0.55

1.60

nmol/l

1.15

395

2673

Injuries to the ankle and foot

600

3848

1.43

15.08

1.2

1.3

0.57

1.31

nmol/l

1.10

583

3704

Congenital malformations, deformations and chromosomal abnormalities

516

3392

1.46

15.01

1.5

1.3

2.57

1.10

nmol/l

0.33

498

3269

Hyperkalaemia

148

3.51

15.00

1.3

1.4

0.71

0.65

nmol/l

0.26

141

Transient ischemic attack

434

2376

1.52

14.95

1.3

0.61

1.93

nmol/l

1.25

418

2270

Other diseases of hard tissues of teeth

564

2917

1.45

14.93

1.3

2.43

1.13

nmol/l

0.31

541

2817

Explicit Sepsis

336

2019

1.60

14.92

1.4

1.2

0.67

2.00

nmol/l

1.01

321

1937

Heart failure, strict

471

2273

1.50

14.77

1.3

3.03

1.41

nmol/l

0.31

441

2173

Persons with potential health hazards related to communicable diseases

322

1990

1.61

14.73

1.3

0.54

1.22

nmol/l

0.62

309

1924

Excessive, frequent and irregular menstruation

361

1255

1.61

14.73

1.3

0.56

1.83

nmol/l

0.72

346

1202

Substance use, excluding alcohol

186

996

1.89

14.70

1.3

0.65

1.71

nmol/l

0.45

177

960

Sequelae of external causes of morbidity and mortality

222

1257

1.78

14.63

1.2

1.3

0.61

2.70

nmol/l

1.00

215

1208

Thyrotoxicosis

240

1395

1.74

14.44

1.2

1.3

0.62

1.75

nmol/l

0.70

229

1339

Early onset COPD, excluding more controls

175

926

1.90

14.32

1.2

1.3

0.60

2.42

nmol/l

0.86

164

892

Carpal tunnel syndrome

538

3386

1.44

14.31

1.2

1.3

2.52

1.44

nmol/l

0.23

521

3251

Later onset COPD, excluding more controls

168

675

1.96

14.26

1.3

5.81

2.82

nmol/l

0.24

159

646

Calculus of kidney and ureter

247

1452

1.71

14.25

1.2

1.3

0.64

2.42

nmol/l

0.97

241

1396

Cardiomyopathy

146

729

2.02

14.19

1.3

0.74

0.86

nmol/l

0.22

139

705

Arthrosis

634

2470

1.42

14.16

1.3

1.27

1.17

nmol/l

0.04

610

2376

Gonarthrosis,primary

767

3546

1.37

14.13

1.2

1.3

1.37

1.55

nmol/l

0.09

741

3407

Insulin, fast-acting

300

1859

1.62

14.07

1.3

4.07

1.55

nmol/l

0.33

291

1791

Benign neoplasm: Rectum, anus and anal canal

171

906

1.91

14.00

1.5

1.2

0.68

3.52

nmol/l

0.96

163

868

Sequelae with surgical and medical care as external cause

180

970

1.87

13.99

1.3

0.63

1.82

nmol/l

0.50

174

931

Conduction disorders

223

1058

1.76

13.87

1.3

0.64

1.87

nmol/l

0.58

216

1020

Other symptoms and signs involving cognitive functions and awareness

340

2040

1.57

13.84

1.3

1.90

1.81

nmol/l

0.02

319

1957

Allergic asthma (mode), excluding more controls

203

1116

1.80

13.83

1.2

1.3

0.51

1.12

nmol/l

0.84

195

1079

Pain and other conditions associated with female genital organs and menstrual cycle

181

938

1.87

13.83

1.2

0.51

2.23

nmol/l

0.74

175

903

Personality disorders

246

1458

1.70

13.79

1.2

2.26

1.48

nmol/l

0.17

236

1408

Polyarthrosis

191

1009

1.83

13.74

1.2

1.3

5.05

1.81

nmol/l

0.32

181

960

COPD related to multimorbidity

298

1553

1.63

13.72

1.3

3.55

2.46

nmol/l

0.14

280

1483

Unstable angina pectoris

301

1551

1.62

13.60

1.3

0.68

1.79

nmol/l

0.78

286

1476

All-cause Heart Failure

457

2235

1.48

13.55

1.3

3.10

1.43

nmol/l

0.31

428

2136

Phobic anxiety disorders

119

561

2.14

13.50

1.2

1.3

4.01

0.54

nmol/l

0.49

114

546

Other disorders of bladder

108

493

2.22

13.34

1.2

1.3

0.57

0.63

nmol/l

1.33

102

471

Parodontitis and operation codes

744

4299

1.35

13.24

1.3

0.64

1.49

nmol/l

1.35

711

4144

Intracranial injury

469

3133

1.45

13.21

1.2

1.3

0.57

1.50

nmol/l

1.15

456

3007

Other septicaemia

285

1740

1.62

13.18

1.4

1.3

0.69

2.24

nmol/l

1.02

271

1664

Injuries to the head

947

4730

1.31

13.17

1.3

1.68

1.19

nmol/l

0.21

905

4563

Haemorrhoids and perianal venous thrombosis

230

1355

1.71

13.16

1.3

0.62

2.70

nmol/l

1.10

223

1305

Mental and behavioural disorders due to psychoactive substance use

485

3188

1.44

13.08

1.2

1.3

0.63

1.52

nmol/l

1.10

464

3084

Other disorders of ear

797

3983

1.34

13.04

1.3

0.61

1.57

nmol/l

1.45

765

3839

Diseases of salivary glands

176

964

1.84

13.02

1.3

0.59

1.79

nmol/l

0.51

171

928

Allergic asthma (mode)

203

1139

1.76

12.94

1.2

1.3

0.51

2.02

nmol/l

0.89

195

1100

Injury, poisoning and certain other consequences of external causes

499

1721

1.46

12.85

1.2

1.3

2.89

1.32

nmol/l

0.29

478

1660

Other and unspecified disorders of vitreous body

361

2375

1.52

12.82

1.2

1.3

0.61

2.17

nmol/l

1.39

345

2275

Adhesive capsulitis of shoulder

154

813

1.91

12.80

1.3

0.66

2.05

nmol/l

0.49

146

780

Insulin, fast-acting or short human

302

1921

1.58

12.74

1.3

4.05

1.52

nmol/l

0.33

293

1850

Substance abuse

471

3140

1.44

12.65

1.2

1.3

0.63

1.53

nmol/l

1.10

450

3038

Osteoporosis

224

1265

1.70

12.58

1.4

1.3

4.40

1.91

nmol/l

0.29

214

1202

Temporomandibular joint disorders, including avohilmo

364

2419

1.51

12.55

1.3

1.2

0.56

1.21

nmol/l

0.71

348

2336

Acute bronchitis

329

2098

1.54

12.54

1.2

1.3

0.58

1.95

nmol/l

1.14

312

2023

Other extrapyramidal and movement disorders in other diseases

195

1115

1.76

12.52

1.3

0.61

2.04

nmol/l

0.72

188

1071

All pneumoniae

876

4627

1.31

12.52

1.3

1.60

1.23

nmol/l

0.14

820

4482

Cardiodefibrillation

281

1765

1.60

12.49

1.3

0.71

2.24

nmol/l

1.03

264

1685

Chronic sinusitis

369

2465

1.50

12.46

1.2

1.3

2.87

1.75

nmol/l

0.20

356

2366

Pneumonias (Asthma/COPD co-morbidities)

871

4618

1.31

12.46

1.3

1.61

1.23

nmol/l

0.14

815

4475

Other diseases of anus and rectum

225

1338

1.69

12.45

1.3

4.29

2.71

nmol/l

0.17

218

1293

Other retinal disorders

511

2903

1.42

12.44

1.3

2.69

1.20

nmol/l

0.33

491

2787

Cyst of kidney

267

2.63

12.37

1.3

0.83

0.66

nmol/l

0.31

252

Artrosis, including avohilmo

737

3008

1.35

12.34

1.3

1.15

1.42

nmol/l

0.14

711

2897

Other noninflammatory disorders of uterus, except cervix

214

845

1.74

12.34

1.3

1.2

0.68

2.50

nmol/l

0.68

202

810

Thyroiditis, ILD-related definition

111

529

2.12

12.34

1.3

0.58

2.75

nmol/l

0.50

106

510

Benign neoplasm: Rectum

150

796

1.90

12.30

1.4

1.2

0.69

3.92

nmol/l

0.96

144

763

Fenamates

136

458

2.02

12.30

1.4

1.3

0.64

2.07

nmol/l

0.79

129

436

Gout

198

1041

1.75

12.13

1.2

1.3

0.63

1.99

nmol/l

0.65

177

993

Atherosclerosis, excluding cerebral and coronary sclerosis

303

1549

1.57

12.12

1.3

4.23

1.80

nmol/l

0.30

283

1481

Other arthrosis

439

2164

1.46

12.10

1.3

0.61

1.27

nmol/l

0.66

418

2078

Transport accidents

382

2286

1.49

12.08

1.2

1.3

2.75

1.61

nmol/l

0.21

369

2218

Benign neoplasm: Caecum

417

2.26

12.07

1.3

0.65

nmol/l

0.01

401

Other and unspecified polyneuropathies, also in other diseases

157

851

1.86

12.06

1.3

0.68

1.87

nmol/l

0.47

150

816

Non-ischemic cardiomyopathy

232

1145

1.67

12.01

1.3

0.71

2.16

nmol/l

0.75

219

1094

Diseases of liver

285

1819

1.58

11.95

1.3

0.65

2.17

nmol/l

1.06

276

1751

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

415

2498

1.46

11.92

1.2

1.3

0.55

1.21

nmol/l

0.75

400

2411

COPD, hospital admissions

346

1940

1.52

11.92

1.3

3.14

2.09

nmol/l

0.16

326

1848

Septicaemia

311

1946

1.54

11.87

1.4

1.3

0.69

2.07

nmol/l

1.01

296

1868

Other disorders of skin and subcutaneous tissue

561

3738

1.38

11.82

1.3

2.14

1.42

nmol/l

0.19

534

3599

COPD, early/later onset

348

1954

1.51

11.77

1.3

3.13

2.08

nmol/l

0.16

328

1862

Irregular menses

416

2327

1.46

11.69

1.2

0.55

1.25

nmol/l

0.76

404

2243

AV-block

127

585

1.99

11.69

1.3

0.68

0.95

nmol/l

0.46

122

564

Specific personality disorders

206

1221

1.70

11.64

1.2

2.59

1.66

nmol/l

0.17

197

1179

Certain disorders involving the immune mechanism

175

992

1.78

11.62

1.2

1.3

0.57

2.19

nmol/l

0.73

168

958

Ventral hernia

203

1200

1.71

11.60

1.4

1.3

0.63

2.80

nmol/l

0.98

195

1155

Injuries to the neck

191

1111

1.73

11.57

1.2

1.3

0.55

1.60

nmol/l

0.51

185

1071

Benign neoplasm: Rectum, anus and anal canal

171

966

1.79

11.50

1.5

1.3

0.68

2.26

nmol/l

0.68

163

928

Other symptoms and signs involving the urinary system

388

2.27

11.44

1.3

0.60

0.62

nmol/l

0.19

367

Peripheral artery disease

320

1692

1.53

11.41

1.3

3.99

1.70

nmol/l

0.30

303

1615

Unspecified haematuria

310

1737

1.54

11.39

1.3

0.68

2.22

nmol/l

1.02

296

1675

ILD medications: immunosuppressive drugs

518

3593

1.39

11.38

1.3

0.61

1.43

nmol/l

1.16

496

3473

Benign neoplasm: Colon, unspecified

190

1104

1.73

11.36

1.3

0.65

3.01

nmol/l

0.98

177

1057

Pneumonia, organism unspecified

772

4265

1.31

11.34

1.3

0.64

1.29

nmol/l

1.07

720

4131

Mouth breathing

340

2280

1.50

11.32

1.2

1.3

0.56

1.84

nmol/l

1.16

330

2202

Asthma and allergy, excluding more controls

112

546

2.04

11.32

1.2

1.3

0.49

0.54

nmol/l

1.08

107

532

Thoracic aortic aneurysm

108

527

2.07

11.31

1.3

0.63

0.65

nmol/l

0.16

103

504

Missing teeth due to accident, extraction or parodontitis

107

521

2.08

11.28

1.3

4.57

2.79

nmol/l

0.16

101

502

Stroke, including SAH

503

2670

1.40

11.21

1.4

1.3

2.30

1.77

nmol/l

0.12

480

2562

Asthma and allergy

112

548

2.03

11.21

1.2

1.3

0.49

0.55

nmol/l

1.55

107

532

Inflammatory disease of uterus

134

708

1.91

11.19

1.2

0.53

2.17

nmol/l

0.52

127

689

Erysipelas

438

2814

1.43

11.19

1.2

1.3

0.59

1.69

nmol/l

1.25

418

2706

Deforming dorsopathies

226

1387

1.64

11.18

1.3

0.64

2.66

nmol/l

1.07

217

1328

Polyneuropathies and other disorders of the peripheral nervous system

172

982

1.77

11.16

1.3

0.68

1.70

nmol/l

0.47

165

945

Other diseases of blood and blood-forming organs, wide

189

1111

1.72

11.06

1.4

1.3

0.66

2.02

nmol/l

0.67

181

1069

Benign neoplasm: Stomach

446

2.16

11.05

1.3

0.63

0.65

nmol/l

0.20

428

Disorders of adult personality and behaviour

245

1539

1.60

11.03

1.2

2.25

1.43

nmol/l

0.18

236

1487

Other diseases of liver

161

906

1.79

11.00

1.4

1.3

0.64

2.34

nmol/l

0.68

156

872

Oxicams

184

593

1.77

10.97

1.3

0.64

1.76

nmol/l

0.82

177

570

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

470

3314

1.40

10.93

1.2

1.3

0.56

1.12

nmol/l

0.88

455

3190

Menorrhagia

314

1131

1.54

10.91

1.3

0.59

1.99

nmol/l

0.71

298

1085

Meniscus derangement

472

2298

1.41

10.90

1.3

0.60

1.22

nmol/l

0.65

459

2209

Artificial joint operation, meniscal resection

765

3901

1.31

10.86

1.2

1.3

0.83

1.56

nmol/l

0.81

735

3758

Stroke, excluding SAH

472

2504

1.41

10.83

1.4

1.3

2.41

1.85

nmol/l

0.11

451

2396

Conjunctivitis (acute, non atopic)

234

1456

1.61

10.82

1.3

1.2

0.57

1.80

nmol/l

0.84

219

1409

Nonalcoholic fatty liver disease

444

2.15

10.78

1.3

0.61

0.62

nmol/l

0.10

427

Allergic conjunctivitis

493

3523

1.38

10.67

1.2

1.3

0.56

1.39

nmol/l

1.14

477

3390

Unspecified kidney failure

324

2.34

10.65

1.4

1.3

0.70

0.65

nmol/l

0.45

308

Other and unspecified nerve root and plexus disorders, also in other diseases

164

943

1.75

10.42

1.2

1.3

0.56

2.48

nmol/l

0.85

157

910

Trochanteric bursitis

124

655

1.91

10.40

1.3

7.38

2.41

nmol/l

0.32

118

625

Dental caries 3 and operation codes

776

3059

1.31

10.34

1.3

0.62

1.59

nmol/l

1.18

743

2957

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

835

4587

1.28

10.29

1.3

1.66

1.24

nmol/l

0.16

780

4445

Myocardial infarction, strict

369

1856

1.46

10.29

1.4

1.3

3.52

1.69

nmol/l

0.27

353

1776

Dental operations, only avohilmo

596

2262

1.35

10.22

1.3

0.64

1.48

nmol/l

0.89

571

2181

Other postsurgical states

251

2.51

10.19

1.6

1.4

0.52

0.64

nmol/l

2.44

239

Bacterial infection, other or unspecified

404

2574

1.42

10.18

1.4

1.3

0.69

1.79

nmol/l

1.09

382

2475

Extrapyramidal and movement disorders

290

1931

1.51

10.11

1.4

1.3

0.61

2.09

nmol/l

1.12

278

1852

Paracetamol of NSAID medication

131

341

1.94

10.08

1.3

1.2

0.54

2.44

nmol/l

0.80

123

332

Disorders of choroid and retina

651

3601

1.32

10.05

1.3

4.02

1.08

nmol/l

0.65

621

3469

Benign neoplasm: Rectum

150

851

1.78

10.02

1.4

1.3

0.69

1.99

nmol/l

0.47

144

816

Dental pulpitis 2, only avohilmo

604

2303

1.35

10.00

1.3

0.63

1.92

nmol/l

1.18

579

2218

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

120

3.25

9.94

1.2

0.62

nmol/l

0.01

112

COPD-related respiratory insufficiency

406

2.14

9.88

1.4

1.2

0.73

0.65

nmol/l

1.05

387

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

231

2.34

9.83

1.5

1.2

12.75

0.66

nmol/l

0.49

221

Nontoxic multinodular goitre

178

1065

1.69

9.83

1.3

0.64

1.75

nmol/l

0.52

170

1015

Benign neoplasm: Caecum

454

2.08

9.82

1.3

0.65

0.66

nmol/l

0.04

432

Dental operations

555

2103

1.36

9.76

1.3

0.64

1.34

nmol/l

0.68

531

2030

Other arthritis (FG)

254

1657

1.54

9.76

1.2

1.3

0.61

2.05

nmol/l

0.90

238

1593

Other acute lower respiratory infections

408

2785

1.40

9.67

1.3

0.57

1.62

nmol/l

1.15

386

2683

Nontoxic goitre/thyroid nodule

268

1774

1.52

9.66

1.4

1.3

0.63

1.54

nmol/l

0.73

257

1696

Other specified/unspecified arthritis

222

1410

1.58

9.62

1.2

1.3

0.60

1.58

nmol/l

0.63

206

1351

Dental pulpitis 2

587

2244

1.34

9.61

1.3

0.64

1.95

nmol/l

1.17

560

2163

Dental caries, including avohilmo

660

2564

1.32

9.57

1.3

0.63

1.79

nmol/l

1.17

631

2470

Cystic kidney disease

118

3.20

9.52

1.5

1.3

0.72

0.62

nmol/l

0.58

111

Pregnancy hypertension

358

2261

1.43

9.50

1.2

1.3

0.54

1.27

nmol/l

0.77

346

2183

Haemorrhage, not elsewhere classified

3.43

9.48

1.4

1.2

1.36

0.65

nmol/l

0.88

Dental caries 3, only avohilmo

710

2791

1.30

9.48

1.3

0.63

1.68

nmol/l

1.16

680

2698

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

207

1298

1.60

9.46

1.3

1.2

0.59

1.58

nmol/l

0.57

198

1257

Asthma-related pneumonia or sepsis

268

1781

1.51

9.39

1.4

1.3

3.91

2.10

nmol/l

0.22

242

1711

Asthma, hospital admissions 3, pneumonia

268

1781

1.51

9.39

1.4

1.3

3.91

2.10

nmol/l

0.22

242

1711

Dental caries 1

659

2567

1.32

9.38

1.3

0.63

1.79

nmol/l

1.17

631

2472

Gout, idiopatic and unspecified

169

1010

1.68

9.37

1.2

1.3

0.62

1.85

nmol/l

0.62

150

970

Gout, FINNGEN

198

1233

1.62

9.33

1.2

1.3

0.63

0.81

nmol/l

0.73

177

1184

Benign neoplasm: Colon, unspecified

190

1172

1.63

9.33

1.3

0.65

2.88

nmol/l

0.99

177

1124

Leiomyoma of uterus

414

1660

1.41

9.32

1.3

1.2

0.58

1.54

nmol/l

0.72

396

1598

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

390

2.13

9.29

1.2

1.3

0.52

0.63

nmol/l

2.86

371

Asthma-related pneumonia

267

1779

1.51

9.25

1.4

1.3

3.92

2.10

nmol/l

0.22

241

1709

Rosacea

102

527

1.96

9.21

1.2

1.3

0.60

0.62

nmol/l

0.19

507

Combinations of oral blood glucose lowering drugs

214

1363

1.58

9.19

1.3

0.69

2.25

nmol/l

0.76

205

1305

Hernia of abdominal wall

357

2524

1.42

9.16

1.3

0.63

1.81

nmol/l

1.17

345

2432

Disorders of lens

562

2666

1.33

9.16

1.3

4.57

0.87

nmol/l

0.73

532

2571

Leiomyoma of uterus

561

2394

1.34

9.13

1.3

1.2

0.59

1.62

nmol/l

1.03

534

2311

Dental caries 1, only avohilmo

670

2628

1.31

9.12

1.3

0.64

1.76

nmol/l

1.16

641

2533

COPD, hospital admission 2, with asthma infections

221

1205

1.57

9.12

1.3

4.61

2.97

nmol/l

0.16

203

1151

Chronic laryngitis and laryngotracheitis

121

663

1.84

9.12

1.2

1.3

0.62

2.37

nmol/l

0.51

121

634

Fissure and fistula of anal and rectal regions

185

1140

1.63

9.12

1.2

1.3

0.58

3.05

nmol/l

1.11

173

1106

Venous thromboembolism

417

2939

1.38

9.10

1.3

0.64

1.66

nmol/l

1.18

403

2814

Ischaemic Stroke, excluding all haemorrhages

426

2333

1.39

9.10

1.3

2.61

1.95

nmol/l

0.13

406

2229

Retention of urine

223

1208

1.57

9.08

1.3

0.64

1.65

nmol/l

0.61

214

1160

Spondylolisthesis/Spondylolysis

149

870

1.73

9.03

1.2

1.3

0.65

2.43

nmol/l

0.69

144

836

Dental caries 3

693

2735

1.30

8.99

1.3

0.63

1.71

nmol/l

1.17

663

2640

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

294

2009

1.47

8.98

1.3

0.52

1.44

nmol/l

0.88

286

1937

Primary gonarthrosis, bilateral

401

2536

1.39

8.89

1.2

1.3

0.60

1.87

nmol/l

1.16

387

2422

Benign neoplasm: Stomach

487

1.98

8.81

1.3

0.63

0.64

nmol/l

0.14

467

Benign neoplasm: Kidney

140

2.92

8.81

1.5

1.3

0.68

0.61

nmol/l

0.65

131

Procreative management

274

1562

1.49

8.74

1.9

1.3

0.50

1.70

nmol/l

0.90

266

1512

Other disorders of eyelid

339

2314

1.42

8.71

1.2

1.3

3.08

1.88

nmol/l

0.19

325

2213

Exposure to other specified factors

598

4320

1.30

8.71

1.3

0.56

1.29

nmol/l

1.26

578

4162

Benign neoplasm: Kidney

141

2.90

8.71

1.5

1.3

0.68

nmol/l

0.04

133

Triptan medication for migraine, min. 3 purchases

464

2716

1.35

8.63

1.3

0.54

1.22

nmol/l

0.87

452

2623

Special screening examination for infectious and parasitic diseases

170

769

1.66

8.59

1.3

0.50

2.85

nmol/l

0.85

163

743

Diseases of external ear

259

1747

1.49

8.57

1.3

0.58

2.10

nmol/l

1.02

250

1686

Voice disturbances

221

1443

1.54

8.55

1.3

0.62

1.70

nmol/l

0.70

208

1392

Symptoms and signs involving speech and voice

269

1834

1.48

8.45

1.3

0.61

1.47

nmol/l

0.71

252

1768

Hyperfunction of pituitary gland

172

2.65

8.38

1.6

1.2

0.55

0.56

nmol/l

0.13

163

Presence of other functional implants

444

2322

1.36

8.37

1.3

4.81

1.40

nmol/l

0.59

430

2215

Dental caries 1 and operation codes

725

2917

1.28

8.37

1.3

0.63

1.64

nmol/l

1.16

696

2815

Emotionally unstable personality disorder

101

538

1.89

8.35

1.1

1.3

0.53

0.54

nmol/l

0.02

522

Pulmonary heart disease, diseases of pulmonary circulation

237

1579

1.51

8.33

1.4

1.3

0.68

2.29

nmol/l

0.95

227

1515

Neuromuscular dysfunction of bladder

394

2.05

8.31

1.3

0.59

0.64

nmol/l

0.50

379

Other bacterial intestinal infections

136

795

1.72

8.25

1.3

0.59

2.09

nmol/l

0.53

127

764

Neuroendocrine tumor and carcinoma of small intestine

4.68

8.19

1.2

0.61

0.50

nmol/l

0.70

Propionic acid derivatives

215

688

1.58

8.19

1.2

1.3

0.56

1.58

nmol/l

0.88

201

662

Injuries to the abdomen, lower back, lumbar spine and pelvis

292

2022

1.44

8.14

1.2

1.3

0.60

2.00

nmol/l

1.10

280

1943

Familial hypercholesterolemia

109

600

1.83

8.13

1.4

1.3

0.65

0.67

nmol/l

0.18

104

578

Other and unspecified drugs and medicaments

372

2.07

8.05

1.2

1.3

0.53

0.64

nmol/l

2.51

354

Viral pneumonia

101

545

1.87

8.04

1.3

0.62

nmol/l

0.05

529

Deviated nasal septum

253

1721

1.48

8.02

1.3

0.59

2.35

nmol/l

1.21

248

1660

Unspecific neurodegenerative disorder

104

1278

0.56

8.01

1.2

1.3

0.63

0.84

nmol/l

0.85

1213

Hyperplasia of prostate

237

891

1.52

7.99

1.4

1.3

0.61

2.25

nmol/l

0.76

223

859

Diseases of male genital organs

369

1334

1.40

7.98

1.3

1.4

0.55

1.66

nmol/l

0.79

349

1294

Oter anti-inflammatory and antirheumatic agents, non-steroids

163

544

1.67

7.98

1.2

1.3

0.62

1.87

nmol/l

0.84

153

522

Gout, strict definition

119

677

1.77

7.97

1.2

1.3

0.62

2.20

nmol/l

0.52

102

650

Benign leiomyoma with endometriosis

149

903

1.67

7.95

1.3

1.2

0.57

2.39

nmol/l

0.74

144

865

Senile cataract

507

2381

1.33

7.94

1.3

2.72

0.82

nmol/l

0.44

479

2295

TMD related operations

144

865

1.68

7.94

1.3

0.54

1.90

nmol/l

0.52

135

839

Pulmonary embolism

218

1445

1.52

7.88

1.4

1.3

0.66

2.45

nmol/l

0.97

211

1386

N06DA Anticholinesterases

1106

0.50

7.87

1.2

1.3

0.60

0.71

nmol/l

1.49

1048

Use of anticholinesterases

1106

0.50

7.87

1.2

1.3

0.60

0.71

nmol/l

1.49

1048

Gout, unspecified

137

814

1.69

7.86

1.2

1.3

0.62

1.94

nmol/l

0.52

122

782

Pulmonary heart disease

218

1446

1.52

7.86

1.4

1.3

0.66

2.45

nmol/l

0.97

211

1386

Diseases of appendix

611

4363

1.28

7.82

1.2

1.3

0.57

1.28

nmol/l

1.25

586

4212

Glomerulonephritis

431

1.97

7.81

1.1

1.3

0.61

0.62

nmol/l

0.13

413

Metatarsalgia

439

1.96

7.76

1.2

1.3

0.60

3.24

nmol/l

0.51

422

Appendicitis, broad definition

605

4335

1.28

7.75

1.2

1.3

0.57

1.28

nmol/l

1.25

580

4185

Restless leg syndrome

105

582

1.82

7.71

1.3

0.61

0.63

nmol/l

0.23

100

556

Bipolar affective disorders

153

941

1.64

7.69

1.2

1.3

3.36

1.76

nmol/l

0.23

146

915

Early onset COPD

175

1116

1.58

7.58

1.2

1.3

0.60

2.95

nmol/l

0.99

164

1074

Superficial injury of lower leg

193

1260

1.54

7.53

1.2

1.3

0.58

1.83

nmol/l

0.71

184

1217

Alzheimer disease

893

0.47

7.52

1.2

1.3

0.65

0.72

nmol/l

0.91

846

Localized swelling, mass and lump of skin and subcutaneous tissue

243

1665

1.47

7.50

1.4

1.3

0.65

2.17

nmol/l

0.95

238

1604

Rash and other nonspecific skin eruption

459

1.92

7.47

1.3

0.60

0.63

nmol/l

0.22

442

Other abnormal uterine and vaginal bleeding

194

896

1.55

7.46

1.2

0.66

2.38

nmol/l

0.68

187

857

Alzheimer disease, including avohilmo

1074

0.53

7.43

1.2

1.3

0.65

0.71

nmol/l

0.61

1019

Atopic dermatitis

443

2858

1.33

7.39

1.2

1.3

0.55

1.55

nmol/l

1.13

424

2760

Cerebral aneurysm, nonruptured

406

1.97

7.35

1.5

1.3

0.64

nmol/l

0.03

390

Appendectomy

535

4009

1.29

7.35

1.3

0.57

1.29

nmol/l

1.13

515

3857

Cellulitis

166

1054

1.58

7.34

1.3

0.57

0.60

nmol/l

0.66

158

1010

Any dementia

1198

0.56

7.29

1.2

1.3

0.65

0.70

nmol/l

0.87

1139

Acute appendicitis

566

4188

1.28

7.27

1.2

1.3

0.57

1.30

nmol/l

1.24

542

4046

Other benign neoplasms of skin

270

1861

1.43

7.27

1.3

1.2

0.61

2.02

nmol/l

1.00

264

1787

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

136

748

1.66

7.24

1.2

1.3

0.48

0.47

nmol/l

0.20

131

723

Internal derangement of knee

291

2071

1.41

7.20

1.3

0.61

1.27

nmol/l

0.63

280

1990

Preparation and fitting of bite rail to mouth

116

677

1.73

7.16

1.3

0.54

2.27

nmol/l

0.52

108

656

Mental and behavioural disorders due to alcohol, excluding acute intoxication

329

2398

1.38

7.12

1.2

1.3

0.62

1.83

nmol/l

1.14

312

2318

Sequelae of cerebrovascular disease

237

1430

1.46

7.08

1.3

4.25

2.62

nmol/l

0.18

221

1366

Dissociative [conversion] disorders

146

2.64

7.07

1.6

1.3

0.46

0.58

nmol/l

1.74

138

Heart failure and bmi 25plus

278

1351

1.43

7.00

1.3

0.74

1.68

nmol/l

0.74

261

1298

KRA_PSY_EATING, excluding more controls

263

2.18

7.00

1.4

1.2

0.47

nmol/l

0.03

257

Dementia, including avohilmo

139

1527

0.63

6.92

1.2

1.3

0.64

1.78

nmol/l

0.89

124

1454

Problems related to lifestyle

429

1.90

6.90

1.3

0.61

0.58

nmol/l

0.39

412

Alcohol use disorder, Swedish definition

404

2835

1.33

6.87

1.2

1.3

0.64

1.64

nmol/l

1.12

384

2744

188

1100

1.52

6.87

1.2

1.3

0.71

0.68

nmol/l

0.47

177

1051

Impingement syndrome of shoulder

192

1280

1.51

6.84

1.3

0.58

1.70

nmol/l

0.66

180

1224

Fracture of lower leg, including ankle

434

3307

1.31

6.84

1.2

1.3

0.61

1.77

nmol/l

1.44

426

3174

Later onset COPD

173

879

1.55

6.82

1.3

5.66

2.09

nmol/l

0.32

164

837

Other female pelvic inflammatory diseases

151

956

1.59

6.82

1.3

1.2

0.61

2.24

nmol/l

0.70

146

925

Coxarthrosis

378

1909

1.35

6.82

1.3

0.67

1.37

nmol/l

0.60

362

1831

COPD, hospital admissions 3, with asthma pneumonia sepsis

171

943

1.55

6.76

1.3

5.92

3.18

nmol/l

0.21

153

901

Contact with and exposure to communicable diseases

234

1619

1.45

6.76

1.4

1.2

0.53

1.23

nmol/l

0.50

223

1572

Female genital prolapse

250

999

1.45

6.75

1.3

0.62

2.19

nmol/l

0.70

244

959

Malignant neoplasm of small intestine

3.37

6.74

1.2

1.3

0.62

0.57

nmol/l

0.26

Acute appendicitis, no complications

440

3372

1.31

6.73

1.2

1.3

0.56

1.42

nmol/l

1.14

427

3258

Bacterial intestinal infections, IBD co-morbidities

132

813

1.63

6.67

1.3

0.59

2.05

nmol/l

0.52

123

781

Abnormal serum enzyme levels

196

1302

1.49

6.66

1.3

0.68

1.58

nmol/l

0.58

189

1243

Disorders of sclera, cornea, iris and ciliary body

424

3250

1.31

6.62

1.3

5.19

1.17

nmol/l

0.65

413

3119

Achilles tendinitis

464

1.85

6.62

1.1

1.3

0.56

3.96

nmol/l

0.72

449

Monoamine oxidase A inhibitors

105

611

1.73

6.60

1.4

1.3

0.64

2.48

nmol/l

0.49

100

591

Dementia

126

1400

0.62

6.60

1.2

1.3

0.64

1.57

nmol/l

0.65

113

1332

Chronic diseases of tonsils and adenoids

654

3324

1.25

6.56

1.3

0.58

1.44

nmol/l

1.12

634

3202

Gonarthrosis, primary, with knee surgery

420

2622

1.31

6.54

1.2

1.3

1.04

1.83

nmol/l

0.50

403

2504

Presence of cardiac and vascular implants and grafts

314

1738

1.37

6.50

1.3

4.04

1.66

nmol/l

0.31

301

1654

All influenza

177

1174

1.51

6.48

1.4

1.3

5.31

2.80

nmol/l

0.22

170

1139

Any event in hilmo or specialist outpatient

+∞

6.47

1.8

0.0

0.39

—

nmol/l

—

Vitamin D deficiency

3.37

6.47

1.2

1.3

0.62

0.51

nmol/l

1.04

Degeneration of macula and posterior pole

333

2033

1.36

6.46

1.2

1.3

0.68

1.38

nmol/l

0.85

317

1930

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

253

2.15

6.45

1.2

0.58

0.64

nmol/l

0.75

241

Other menopausal disorders

238

950

1.45

6.44

1.3

0.61

2.26

nmol/l

0.71

228

916

Diabetic nephropathy

135

835

1.61

6.39

1.3

0.76

2.81

nmol/l

0.87

128

807

Other diseases of pleura

306

1990

1.37

6.35

1.3

0.67

2.05

nmol/l

1.05

288

1907

Other and unspecified tonsillitis

246

1475

1.42

6.34

1.4

1.3

0.53

0.69

nmol/l

0.56

241

1427

Aneurysms, operations, SAH

126

780

1.63

6.27

1.5

1.3

0.65

2.64

nmol/l

0.69

119

747

Persistent mood disorders

154

1001

1.55

6.22

1.3

0.61

1.74

nmol/l

0.49

148

967

DVT of lower extremities and pulmonary embolism

296

2168

1.37

6.20

1.4

1.3

0.65

2.03

nmol/l

1.18

287

2074

Mental and behavioural disorders due to alcohol

367

2711

1.32

6.17

1.2

1.3

0.62

1.69

nmol/l

1.14

350

2621

Diabetic nephropathy, excluding more controls

132

689

1.61

6.16

1.4

0.76

1.77

nmol/l

0.80

125

666

Benign leiomyoma with endometriosis

149

965

1.56

6.15

1.3

0.57

2.26

nmol/l

0.74

144

930

Sequelae of injuries, of poisoning and of other consequences of external causes

183

1237

1.49

6.15

1.3

0.54

2.52

nmol/l

0.94

176

1198

Dislocation, sprain and strain of joints and ligaments of knee

477

3480

1.28

6.14

1.2

1.3

0.54

1.39

nmol/l

1.19

467

3356

420

2984

1.30

6.08

1.2

1.3

0.62

1.59

nmol/l

1.13

401

2887

Other disorders of the musculoskeletal system and connective tissue

114

695

1.65

6.06

1.1

1.3

0.57

2.29

nmol/l

0.52

106

665

Other blood glucose lowering drugs, excl. Insulins

123

765

1.62

6.03

1.3

1.2

0.81

3.55

nmol/l

0.74

117

724

Excessive attrition of teeth

311

1239

1.37

5.99

1.3

3.92

0.59

nmol/l

0.49

298

1198

Erosion of teeth, including avohilmo

153

968

1.54

5.96

1.3

1.2

0.57

0.56

nmol/l

0.01

146

935

Early lumbar disc prolapse, operated

401

1.86

5.93

1.2

0.47

1.04

nmol/l

0.58

392

Alzheimer’s disease, wide definition

760

0.47

5.91

1.2

1.3

0.65

0.74

nmol/l

0.91

719

Parodontitis or/and operation codes

543

2569

1.26

5.91

1.3

0.64

1.48

nmol/l

0.91

519

2475

Vasomotor and allergic rhinitis

287

2085

1.36

5.91

1.2

1.3

0.54

1.43

nmol/l

0.88

279

2013

Pure hyperglyceridaemia

3.34

5.89

1.4

1.5

0.48

0.63

nmol/l

1.39

Diseases of the myoneural junction and muscle

542

1.73

5.86

1.4

1.3

0.68

0.64

nmol/l

0.43

514

Non-allergic asthma (mode), excluding more controls

137

872

1.56

5.84

1.2

0.57

1.09

nmol/l

0.56

126

841

Degenerative diseases of the nervous system

1067

0.58

5.83

1.2

1.3

0.67

0.71

nmol/l

0.42

1014

Coxarthrosis [arthrosis of hip](FG)

406

2267

1.30

5.82

1.3

0.67

1.71

nmol/l

0.88

389

2175

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

291

1889

1.36

5.82

1.6

1.2

1.32

2.02

nmol/l

0.30

279

1813

Noninflammatory disorders of female genital tract

340

1278

1.34

5.77

1.2

1.3

0.56

1.81

nmol/l

0.72

327

1225

Cauda equina syndrome

4.01

5.76

1.5

1.3

0.72

0.55

nmol/l

0.60

Otitis externa

165

1109

1.50

5.74

1.3

0.54

2.93

nmol/l

1.02

157

1072

Gluteal tendinitis

139

2.48

5.64

1.2

1.3

0.54

0.60

nmol/l

0.69

133

Anti-inflammatory and antirheumatic products, non-steroids

200

688

1.47

5.62

1.3

0.58

1.58

nmol/l

0.86

191

662

Postmenopausal bleeding

226

874

1.43

5.62

1.2

1.3

0.64

2.44

nmol/l

0.71

221

837

In situ neoplasms

247

1711

1.38

5.59

1.3

1.2

0.64

2.15

nmol/l

0.97

231

1641

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

177

2.29

5.58

1.2

1.3

0.66

0.68

nmol/l

0.12

168

279

1945

1.35

5.56

1.3

3.79

2.11

nmol/l

0.22

256

1855

132

807

1.56

5.49

1.3

0.71

0.69

nmol/l

0.22

124

767

Mycoses

193

1352

1.43

5.44

1.4

1.3

0.59

2.52

nmol/l

0.99

186

1306

Other peripheral vertigo

428

1.79

5.44

1.3

0.62

0.65

nmol/l

0.44

411

Arthropathies in other diseases classified elsewhere

142

2.43

5.41

1.2

1.3

29.95

0.63

nmol/l

0.49

135

Family history of other specific disorders

3.64

5.37

3.4

1.4

0.44

0.47

nmol/l

0.23

Alcohol use disorder, ICD-based

295

2220

1.33

5.36

1.2

1.3

0.61

1.86

nmol/l

1.06

281

2146

Other and unspecified diseases of blood and blood-forming organs

2.83

5.34

1.4

1.2

0.66

0.62

nmol/l

0.31

Disorders of breast

404

2938

1.28

5.33

1.3

1.2

2.65

1.13

nmol/l

0.33

392

2826

Poisoning by drugs, medicaments and biological substances

180

1250

1.45

5.33

1.3

1.2

0.65

1.46

nmol/l

0.43

170

1217

Correction of physiology of bite - demanding therapy visit

323

1.91

5.31

1.4

1.3

0.48

0.60

nmol/l

2.50

310

Atopic dermatitis, strict definition with reimbursement

221

1543

1.39

5.30

1.2

1.3

0.53

1.68

nmol/l

0.83

214

1496

Examination and encounter for administrative purposes

131

2.47

5.30

1.2

1.3

0.60

0.61

nmol/l

0.04

125

438

3117

1.26

5.18

1.2

1.3

0.63

1.54

nmol/l

1.11

418

3016

Non-allergic asthma (mode)

137

898

1.52

5.17

1.2

1.3

0.57

2.24

nmol/l

0.75

126

866

Skin changes due to chronic exposure to nonionizing radiation

257

1802

1.35

5.16

1.3

4.08

2.23

nmol/l

0.22

235

1716

COPD, hospital admissions 1, only main diagnosis

224

1382

1.39

5.12

1.2

1.3

0.66

2.68

nmol/l

1.07

208

1320

Other orthopaedic follow-up care

244

2.03

5.11

1.3

0.60

0.65

nmol/l

0.42

236

Poisoning by medicine

161

1106

1.46

5.07

1.3

0.64

1.58

nmol/l

0.44

151

1075

Unspecified fall

346

2663

1.29

5.06

1.2

1.3

0.57

1.67

nmol/l

1.16

333

2554

Misadventures to patients during surgical and medical care

103

644

1.61

5.02

1.5

1.3

0.56

0.63

nmol/l

1.06

617

Superficial injury of abdomen, lower back and pelvis

107

675

1.59

5.02

1.3

0.55

0.59

nmol/l

0.54

102

643

Actinic keratosis

246

1728

1.36

5.01

1.3

4.25

2.29

nmol/l

0.23

224

1649

Injuries to the thorax

309

2367

1.31

4.98

1.3

0.62

1.88

nmol/l

1.19

294

2281

Autonomic disorders

2.91

4.96

1.5

1.3

0.49

0.60

nmol/l

0.98

Postmenopausal atrophic vaginitis

208

893

1.41

4.95

1.2

1.3

0.63

2.40

nmol/l

0.71

200

856

Fall on same level involving ice and snow

431

3447

1.25

4.93

1.3

3.49

1.36

nmol/l

0.47

413

3316

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

374

1.80

4.91

1.2

1.3

0.66

3.42

nmol/l

0.49

360

Tuberous sclerosis 1

12.60

4.91

2.1

1.6

0.58

0.50

nmol/l

—

Disorders of continuity of bone

442

1.73

4.90

1.2

1.3

0.60

nmol/l

0.02

427

Injuries to the shoulder and upper arm

637

4439

1.21

4.90

1.3

1.24

1.38

nmol/l

0.06

616

4274

Use of other anti-dementia drugs

806

0.53

4.89

1.1

1.3

0.68

0.73

nmol/l

0.31

763

Use of memantine

806

0.53

4.89

1.1

1.3

0.68

0.73

nmol/l

0.31

763

Fracture of rib(s), sternum and thoracic spine

199

1431

1.40

4.88

1.3

0.61

2.30

nmol/l

0.92

189

1381

Iron deficiency anaemia secondary to blood loss (chronic)

111

713

1.57

4.84

1.2

1.3

0.68

2.26

nmol/l

0.48

102

679

Any dementia, excluding more controls

1021

0.63

4.67

1.2

1.3

0.64

1.88

nmol/l

0.63

972

Nonhereditary hypogammaglobulinemia

3.44

4.66

1.0

1.3

0.48

0.51

nmol/l

0.20

Colorectal neuroendocrine tumor and carcinoma

3.29

4.65

1.2

1.3

0.59

0.54

nmol/l

0.28

Medical abortion

528

2341

1.23

4.64

1.3

1.2

0.60

1.28

nmol/l

0.71

514

2238

L04AA Selective immunosuppressants

166

1170

1.43

4.61

1.3

0.61

1.93

nmol/l

0.69

158

1132

Ganglion

154

1072

1.44

4.57

1.3

0.58

1.67

nmol/l

0.51

149

1034

Inflammatory bowel disease

232

1732

1.34

4.54

1.3

0.60

2.20

nmol/l

1.07

226

1673

Benign neoplasm: Ascending colon

552

1.62

4.53

1.6

1.3

10.41

4.59

nmol/l

0.25

532

Other benign neoplasms of skin

270

2061

1.31

4.52

1.3

0.61

1.91

nmol/l

1.02

264

1978

Gastrointestinal stromal tumor and sarcoma

3.37

4.52

2.2

1.3

0.63

0.54

nmol/l

0.80

Other disorders of central nervous system

3.50

4.50

1.2

1.5

0.51

0.54

nmol/l

0.14

Heart failure and coronary heart disease

191

1026

1.39

4.48

1.3

6.42

0.85

nmol/l

0.49

178

974

Haemorrhage in early pregnancy

222

1610

1.35

4.47

1.1

1.3

0.57

1.55

nmol/l

0.72

214

1557

Use of pramipexole

161

1136

1.42

4.46

1.2

1.3

0.60

2.01

nmol/l

0.73

153

1091

Other disorders of pigmentation

175

2.14

4.46

1.3

0.63

0.67

nmol/l

0.20

167

Colonic or urogenital fistula

197

1441

1.37

4.41

1.2

1.3

0.58

2.41

nmol/l

1.01

185

1392

Superficial injury of head

155

1092

1.43

4.33

1.1

1.3

5.93

1.66

nmol/l

0.36

150

1048

Pre-eclampsia or poor fetal growth

229

1716

1.34

4.31

1.2

1.3

0.53

1.46

nmol/l

0.72

221

1663

Fracture of skull and facial bones

150

1054

1.43

4.27

1.3

0.57

1.68

nmol/l

0.51

141

1014

Disorders of ocular muscles, binocular movement, accommodation and refraction

342

2691

1.26

4.25

1.3

3.00

1.62

nmol/l

0.24

333

2592

Ulcer of lower limb, not elsewhere classified

578

1.58

4.22

1.2

1.3

0.80

0.65

nmol/l

0.37

552

Viral infections characterized by skin and mucous membrane lesions

299

2335

1.28

4.22

1.3

3.32

1.81

nmol/l

0.23

292

2245

Allergic rhinitis

222

1650

1.34

4.21

1.2

1.3

0.51

1.51

nmol/l

0.76

215

1598

Hyperprolactinaemia

121

2.34

4.19

1.2

0.52

0.53

nmol/l

0.06

113

L04AD Calcineurin inhibitors

502

1.63

4.17

1.3

0.63

0.60

nmol/l

0.28

484

Other skin changes

114

766

1.50

4.11

1.2

1.3

7.96

2.13

nmol/l

0.36

109

735

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

295

1795

1.29

4.10

1.4

1.2

0.68

2.10

nmol/l

0.94

279

1720

Polyp of the female genital tract

244

1073

1.33

4.10

1.2

0.61

2.07

nmol/l

0.71

233

1031

Supplementary factors related to causes of morbidity and mortality classified elsewhere

213

1598

1.34

4.08

1.3

0.55

2.09

nmol/l

0.95

205

1538

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

162

2.12

4.05

1.2

1.3

0.64

0.68

nmol/l

0.27

153

Eating disorder

324

1.77

4.02

1.4

1.3

0.47

nmol/l

0.03

313

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

206

1542

1.34

4.01

1.3

2.56

2.14

nmol/l

0.07

200

1487

Other disorders of conjunctiva

643

1.53

3.97

1.2

1.3

0.61

2.43

nmol/l

0.51

616

Bicipital tendinitis

191

2.01

3.94

1.2

1.3

0.58

0.63

nmol/l

0.47

185

Other diseases of the respiratory system

124

855

1.46

3.94

1.4

1.3

0.64

1.87

nmol/l

0.50

116

819

Other respiratory disorders and diseases

124

855

1.46

3.94

1.4

1.3

0.64

1.87

nmol/l

0.50

116

819

Unspecified privation

479

1.62

3.93

1.2

1.3

6.14

0.62

nmol/l

0.49

460

In situ neoplasms

247

1904

1.30

3.92

1.3

0.64

2.01

nmol/l

0.99

231

1828

Umbilical hernia

177

1300

1.37

3.92

1.2

1.3

0.63

2.57

nmol/l

0.98

168

1255

Pre-eclampsia or eclampsia

170

1241

1.38

3.91

1.1

1.3

0.54

1.82

nmol/l

0.73

164

1204

Blepharochalasis

214

1618

1.33

3.91

1.2

1.3

0.62

2.29

nmol/l

1.03

204

1543

Injuries to the wrist and hand

765

4775

1.16

3.90

1.3

0.56

1.23

nmol/l

1.30

746

4590

Congenital iodine-deficiency syndrome/hypothyroidism

119

2.30

3.89

1.4

1.1

0.64

0.61

nmol/l

0.19

109

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

307

1.77

3.85

1.6

1.3

0.56

0.67

nmol/l

1.40

295

Other fall from one level to another

147

1050

1.41

3.84

1.2

1.3

6.18

1.57

nmol/l

0.38

142

1009

Melanocytic naevi

197

1476

1.34

3.84

1.4

1.2

0.61

2.35

nmol/l

0.97

192

1426

Complications of internal orthopaedic prosthetic devices, implants and grafts

153

1102

1.39

3.83

1.3

0.67

3.02

nmol/l

0.97

147

1056

Idiopathic gout

338

1.73

3.80

1.2

1.3

0.59

0.65

nmol/l

0.70

322

Sulfonylureas

220

1333

1.32

3.79

1.4

1.3

0.69

2.33

nmol/l

0.78

210

1265

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

167

2.06

3.77

1.2

1.3

0.64

0.69

nmol/l

0.44

157

Polycythaemia vera

134

2.19

3.75

1.1

1.3

0.64

0.71

nmol/l

0.42

125

Fibroblastic disorders

148

1064

1.40

3.75

1.2

1.3

7.58

1.74

nmol/l

0.39

143

1019

Unspecified mental disorder

301

2393

1.26

3.74

1.2

1.3

0.66

1.75

nmol/l

0.98

285

2303

Bronchiectasis

325

1.74

3.73

1.4

1.3

0.66

0.64

nmol/l

0.10

308

Scleritis

3.07

3.72

1.1

1.3

0.67

0.52

nmol/l

1.04

Glaucoma

389

2791

1.23

3.71

1.3

0.62

2.03

nmol/l

1.49

372

2673

Ulcerative colitis

172

1270

1.36

3.70

1.3

0.59

1.64

nmol/l

0.60

166

1229

Acute peritonitis

238

1.86

3.70

1.5

1.2

0.74

0.62

nmol/l

0.75

226

Papulosquamous disorders

289

2291

1.27

3.70

1.2

1.3

3.53

1.84

nmol/l

0.24

275

2209

Other viral diseases

202

1524

1.33

3.69

1.2

1.3

0.55

1.44

nmol/l

0.62

195

1474

Other and unspecified mononeuropathies of lower limb

103

2.36

3.68

1.1

1.3

0.60

0.61

nmol/l

0.06

Urethritis and urethral syndrome

2.51

3.65

1.6

1.2

0.52

0.59

nmol/l

0.46

Pericarditis

129

2.19

3.65

1.9

1.3

0.57

0.60

nmol/l

0.20

122

Wet age-related macular degeneration

636

1.50

3.63

1.2

1.3

0.72

0.70

nmol/l

0.30

609

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.78

3.61

1.2

0.59

0.56

nmol/l

0.12

Prolonged pregnancy

650

0.54

3.61

1.3

0.45

0.50

nmol/l

1.22

629

Type of accident

194

1466

1.33

3.59

1.2

1.3

0.55

2.23

nmol/l

0.94

187

1412

Background retinopathy and retinal vascular changes

2.69

3.58

1.9

1.3

0.66

0.56

nmol/l

0.47

Conductive and sensorineural hearing loss

586

3448

1.18

3.57

1.3

0.62

1.74

nmol/l

1.46

563

3319

Neurofibromatosis, type 2

10.80

3.57

2.5

1.2

0.58

0.42

nmol/l

—

Other obstetric conditions, not elsewhere classified

207

1018

1.32

3.56

1.3

0.48

0.50

nmol/l

0.37

200

986

Benign neoplasm: Ascending colon

589

1.52

3.52

1.6

1.3

10.41

0.65

nmol/l

0.49

565

Benign neoplasm: Nasopharynx

3.64

3.51

1.1

1.5

0.44

0.54

nmol/l

0.45

Calcific aortic valvular stenosis

166

1204

1.35

3.50

1.2

1.3

6.90

0.84

nmol/l

0.48

161

1143

Calcific aortic valvular stenosis, operated

166

1204

1.35

3.50

1.2

1.3

6.90

0.84

nmol/l

0.48

161

1143

Family history of malignant neoplasm

510

1.56

3.49

2.1

1.3

0.53

2.83

nmol/l

0.52

494

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

112

2.26

3.49

2.4

1.3

0.64

0.70

nmol/l

0.46

105

Other congenital malformations of skin

159

2.03

3.46

1.1

1.3

0.55

0.59

nmol/l

0.42

151

Atopic dermatitis, strict definition

204

1530

1.31

3.46

1.2

0.53

1.29

nmol/l

0.52

197

1478

Striking against or struck by other objects

218

1684

1.30

3.44

1.2

1.3

0.51

1.98

nmol/l

0.96

206

1625

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

207

1590

1.31

3.43

1.3

1.2

0.59

1.40

nmol/l

0.58

198

1540

Speech therapy

193

1469

1.32

3.42

1.3

4.97

2.40

nmol/l

0.24

183

1415

Dependent personality disorder

2.48

3.40

1.2

1.3

20.58

0.58

nmol/l

0.48

Calcific aortic valvular stenosis, diagnosis (helper)

165

1203

1.35

3.38

1.2

1.3

6.94

0.84

nmol/l

0.48

160

1142

Operations 2 for CAVS

165

1203

1.35

3.38

1.2

1.3

6.94

0.84

nmol/l

0.48

160

1142

Other and unspecified mononeuropathies, also in other diseases

101

2.30

3.37

1.4

1.3

0.71

0.63

nmol/l

0.28

Respiratory insufficiency

260

1.78

3.36

1.5

1.3

0.72

0.65

nmol/l

0.83

252

Infections with a predominantly sexual mode of transmission

215

1664

1.29

3.35

1.2

1.3

0.53

1.48

nmol/l

0.72

207

1607

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

375

2103

1.22

3.35

1.3

1.2

0.68

1.87

nmol/l

0.93

352

2023

Psoriasis

203

1562

1.30

3.34

1.2

1.3

4.72

2.40

nmol/l

0.23

195

1510

Arterial embolism and thrombosis

189

1.92

3.33

1.4

1.2

0.65

0.64

nmol/l

0.06

179

Calcific aortic valvular stenosis, including rheumatic fever

165

1207

1.34

3.30

1.2

1.3

6.94

0.84

nmol/l

0.48

160

1145

Decubitus ulcer and pressure area

190

1.91

3.29

1.1

1.2

0.95

0.64

nmol/l

0.32

178

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

146

1073

1.37

3.29

1.8

1.3

1.89

3.07

nmol/l

0.28

140

1027

Benign neoplasm: Brain, supratentorial

2.82

3.27

2.2

1.3

0.74

0.50

nmol/l

0.74

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

200

992

1.31

3.26

1.3

1.2

0.48

0.50

nmol/l

0.37

193

960

Renal cell carcinoma of kidney

116

2.18

3.23

2.4

1.3

0.64

0.65

nmol/l

0.08

108

Benign neoplasm: Nasopharynx

3.42

3.22

1.1

1.4

0.44

0.51

nmol/l

0.30

Disorders of psychological development

422

1.57

3.22

1.4

1.3

0.48

0.49

nmol/l

0.09

403

Entropion and trichiasis of eyelid

311

1.68

3.16

1.2

1.3

0.70

0.69

nmol/l

0.01

292

Other hearing loss

166

1231

1.33

3.15

1.3

0.61

2.96

nmol/l

1.12

157

1172

Amiodarone users

397

1.60

3.13

1.4

1.2

0.71

0.67

nmol/l

0.25

377

Early lumbar disc prolapse operation

484

1.54

3.13

1.2

1.3

0.47

0.95

nmol/l

0.60

476

Salpingitis and oophoritis

145

1075

1.36

3.12

1.2

1.3

0.55

2.06

nmol/l

0.75

139

1046

Diabetes mellitus in pregnancy

213

1073

1.29

3.09

1.2

1.3

0.48

1.59

nmol/l

0.53

208

1041

Benign neoplasm: Brain, supratentorial

2.72

3.08

2.2

1.3

0.74

0.54

nmol/l

0.57

Bitten or struck by other mammals

486

1.53

3.08

1.4

1.3

0.60

0.59

nmol/l

0.11

468

Hallux rigidus

104

732

1.43

3.06

1.2

1.3

0.64

2.24

nmol/l

0.50

693

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

113

807

1.41

3.05

1.3

1.2

0.61

3.90

nmol/l

1.00

105

771

Other factor of the environment

2.94

3.05

1.7

1.2

0.42

0.47

nmol/l

0.37

Presbyopia

292

1.69

3.04

1.5

1.4

0.61

0.64

nmol/l

0.23

279

Sensorineural hearing loss

542

3252

1.17

3.03

1.3

0.62

1.81

nmol/l

1.47

520

3129

Other maltreatment syndromes

133

2.05

3.02

1.3

1.4

0.60

0.55

nmol/l

0.25

127

Sequelae of injuries of lower limb

441

1.55

3.00

1.4

1.3

0.56

0.60

nmol/l

0.51

425

Hypothyroidism due to medicaments and other exogenous substances

3.07

3.00

1.4

0.62

0.59

nmol/l

0.09

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

115

828

1.39

2.98

1.3

0.62

1.93

nmol/l

0.47

106

803

Follow-up examination after treatment for malignant neoplasms

363

1.61

2.97

1.8

1.2

0.63

4.99

nmol/l

0.70

345

Methotrexate

103

728

1.42

2.97

1.2

1.3

0.62

2.74

nmol/l

0.69

701

Hypertrophy of breast in women and men

145

1085

1.34

2.96

1.2

1.3

0.62

2.02

nmol/l

0.68

139

1049

Perforation of tympanic membrane

452

1.54

2.92

1.3

0.58

0.62

nmol/l

0.63

433

Other cataract

302

1913

1.23

2.91

1.3

5.02

0.86

nmol/l

0.56

291

1839

Follicular cysts of skin and subcutaneous tissue

125

917

1.37

2.90

1.2

1.3

0.56

1.86

nmol/l

0.53

115

886

Speech disturbances, not elsewhere classified

351

1.61

2.87

1.3

1.2

0.58

0.65

nmol/l

0.67

331

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

112

809

1.39

2.87

1.6

1.3

2.20

3.89

nmol/l

0.30

106

771

Sequelae of injuries of head

200

1.81

2.86

1.2

1.3

0.55

0.62

nmol/l

0.82

190

Keratitis

243

1955

1.25

2.84

1.3

3.97

1.46

nmol/l

0.33

236

1879

Polyglandular dysfunction, other/unspecified

9.44

2.84

2.8

1.2

0.60

0.45

nmol/l

—

Recurring oral aphthae, including avohilmo

660

1.43

2.83

1.3

0.60

0.62

nmol/l

0.13

632

Myocardial infarction, unclassifiable

115

744

1.38

2.82

1.5

1.3

9.75

0.70

nmol/l

0.49

110

709

Paraplegia, diplegia of upper limbs

2.42

2.81

1.2

1.3

0.52

0.57

nmol/l

0.20

Benign neoplasm of ovary

132

983

1.35

2.80

1.3

1.2

0.62

2.25

nmol/l

0.71

125

937

Eating disorders

426

1.53

2.75

1.4

1.3

0.53

nmol/l

0.01

410

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

317

1.62

2.72

1.2

1.3

0.66

0.65

nmol/l

0.09

303

Loose body in joint

2.26

2.71

1.1

1.4

0.54

0.62

nmol/l

0.40

Diagnoses used for exclusion with ILD

163

1257

1.30

2.71

1.3

0.61

2.69

nmol/l

1.00

151

1213

Preterm labour and delivery

199

1575

1.27

2.70

1.2

1.3

4.71

1.57

nmol/l

0.34

193

1522

Scar conditions and fibrosis of skin

175

1.85

2.69

1.2

1.3

0.61

nmol/l

0.03

168

Injuries to the elbow and forearm

508

3970

1.16

2.68

1.3

0.62

1.51

nmol/l

1.31

473

3835

Reimbursement for rheumatic diseases

425

3622

1.17

2.66

1.2

1.3

0.60

1.62

nmol/l

1.37

404

3484

Biological medicines for asthma

2.70

2.64

1.3

0.52

0.50

nmol/l

0.07

Monoplegia

2.50

2.64

1.3

1.2

0.50

0.55

nmol/l

0.36

Vascular syndromes of brain in cerebrovascular disorders

162

1.87

2.63

1.2

1.3

0.64

0.66

nmol/l

0.11

151

Graves disease, strict definition

473

1.49

2.60

1.2

1.3

0.59

0.60

nmol/l

0.04

455

Malignant neoplasm of pancreas

207

1.75

2.58

1.9

1.2

0.57

0.66

nmol/l

0.66

192

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

155

711

1.31

2.56

1.4

1.3

0.65

2.07

nmol/l

0.48

148

688

Suicide or other Intentional self-harm

168

1312

1.28

2.56

1.3

1.2

0.62

1.59

nmol/l

0.57

159

1271

Injury of muscle and tendon at shoulder and upper arm level

240

1955

1.23

2.55

1.2

1.3

0.61

1.95

nmol/l

1.01

232

1877

Bronchitis, not specified as acute or chronic

363

1.55

2.53

1.4

1.3

0.60

nmol/l

0.00

351

Other facial nerve disorders

108

2.06

2.53

1.2

1.4

0.46

0.64

nmol/l

2.51

102

Hallux valgus (acquired)

246

1451

1.23

2.50

1.2

1.3

2.37

1.43

nmol/l

0.21

234

1389

Malignant melanoma, excluding all cancers (controls excluding all cancers)

102

745

1.37

2.49

1.2

1.3

0.65

4.14

nmol/l

0.98

715

Arterial embolism and thrombosis of lower extremity artery

2.12

2.49

1.5

1.2

0.65

0.61

nmol/l

0.19

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

161

760

1.30

2.48

1.4

1.2

0.64

1.97

nmol/l

0.49

154

736

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

181

1418

1.27

2.47

1.4

1.2

0.53

1.35

nmol/l

0.51

175

1367

Pregnancy with abortive outcome

520

2359

1.15

2.46

1.2

0.61

1.27

nmol/l

0.69

502

2255

Other disorders of thyroid

2.59

2.46

1.4

1.3

0.46

0.61

nmol/l

1.12

Pedal cyclist injured in other and unspecified transport accidents

512

1.45

2.46

1.2

1.3

11.43

0.60

nmol/l

0.50

492

Medicines for HER+ breast cancer

190

2307

0.80

2.45

1.4

1.3

4.96

1.32

nmol/l

0.39

184

2215

Otitis media, unspecified

426

1.48

2.43

1.3

13.18

0.55

nmol/l

0.49

409

Malignant neoplasm of breast, HER-positive

180

2223

0.80

2.43

1.4

1.3

5.23

1.35

nmol/l

0.39

174

2135

Idiopathic thrombocytopenic purpura

103

2.06

2.42

1.6

1.3

0.55

0.60

nmol/l

0.52

Other diseases of spinal cord

110

2.02

2.42

1.3

1.2

0.53

0.58

nmol/l

0.31

102

Subacute thyroiditis

160

1.83

2.40

1.2

0.52

0.61

nmol/l

1.69

150

Other inflammatory liver diseases

281

1.61

2.40

1.2

1.3

0.63

0.65

nmol/l

0.19

266

Diseases of middle ear and mastoid

398

2792

1.17

2.40

1.4

1.3

2.65

1.57

nmol/l

0.21

382

2691

Other and unspecified disorders of autonomic nervous system

4.28

2.39

1.6

1.4

0.37

0.42

nmol/l

—

Crohn's disease of small intestine

297

1.59

2.39

1.3

1.4

0.65

0.59

nmol/l

0.52

287

Burns and corrosions confined to eye and internal organs

2.08

2.38

1.2

1.3

0.60

0.58

nmol/l

0.10

Ulcerative ileocolitis

168

1.80

2.37

1.2

1.4

0.55

0.61

nmol/l

0.46

160

Intussusception

2.17

2.36

1.1

1.2

0.56

0.58

nmol/l

0.14

Burn and corrosion confined to eye and adnexa

2.11

2.34

1.2

1.3

0.61

0.57

nmol/l

0.14

Other other unspecified disorders of the circulatory system

140

1.87

2.33

1.3

1.2

0.54

0.62

nmol/l

0.96

131

Melanocytic naevi

197

1590

1.24

2.32

1.4

1.3

0.61

1.57

nmol/l

0.68

192

1536

Disorder of thyroid, unspecified

2.49

2.29

1.4

1.2

0.46

0.62

nmol/l

1.32

Colorectal cancer, excluding all cancers (controls excluding all cancers)

160

1220

1.27

2.29

1.2

1.3

0.62

2.80

nmol/l

1.01

151

1164

Crohn disease (strict definition, require KELA, min 2 HDR)

269

1.61

2.29

1.5

1.4

0.66

0.59

nmol/l

0.60

258

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

569

1.40

2.27

1.1

1.3

0.62

2.49

nmol/l

0.51

546

Other medical care

257

2087

1.20

2.25

1.3

1.35

1.89

nmol/l

0.23

241

2002

Schizophrenia or delusion, excluding more controls

187

1494

1.24

2.25

1.3

0.66

2.16

nmol/l

0.83

174

1448

L04AC Interleukin inhibitors

209

1.69

2.24

1.1

1.3

0.55

0.61

nmol/l

0.55

200

Rheumatoid arthritis

215

1598

1.23

2.22

1.2

1.3

0.65

1.36

nmol/l

0.50

204

1532

6-mercaptopurine

100

2.02

2.21

1.5

1.4

0.55

0.57

nmol/l

0.13

Right bundle-branch block

114

1.94

2.21

1.3

1.2

0.62

0.65

nmol/l

0.18

108

Alcohol dependence

168

1341

1.26

2.20

1.2

1.3

0.62

2.40

nmol/l

0.89

158

1285

5-aminosalicylic acid

140

1093

1.28

2.20

1.2

1.3

0.56

3.12

nmol/l

1.09

133

1057

Suppurative and unspecified otitis media

236

1729

1.21

2.19

1.4

1.3

4.05

0.54

nmol/l

0.49

227

1672

Other misadventures during surgical and medical care

2.26

2.19

1.3

0.52

0.54

nmol/l

0.13

Vestibular neuronitis

402

1.48

2.16

1.2

1.3

0.57

0.65

nmol/l

1.07

384

Injuries involving multiple body regions

144

1.82

2.15

1.0

1.3

0.60

nmol/l

0.02

136

Non-small cell lung cancer

611

1.38

2.15

1.1

1.3

0.62

0.66

nmol/l

0.70

582

Hidradenitis suppurativa

137

1.84

2.14

1.3

0.61

0.54

nmol/l

0.50

130

Hypertrophy of breast

127

984

1.30

2.13

1.2

1.3

0.60

2.16

nmol/l

0.69

122

953

Glaucoma suspect

238

1979

1.21

2.12

1.2

1.3

0.62

1.99

nmol/l

1.03

232

1892

Tuberculosis of other organs

2.23

2.12

1.9

1.2

0.69

0.62

nmol/l

0.14

Benign neoplasm: Short bones of lower limb

2.75

2.12

1.1

1.3

0.66

0.45

nmol/l

—

Somnolence

2.49

2.12

1.7

1.2

67.24

0.47

nmol/l

0.47

Cholesteatoma of external ear

3.27

2.11

1.1

1.5

0.51

0.50

nmol/l

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

614

1.37

2.10

1.2

1.3

0.65

2.34

nmol/l

0.50

589

Seborrhoeic dermatitis

430

1.45

2.09

1.3

0.69

0.64

nmol/l

0.43

414

Diabetic retinopathy, excluding more controls

203

931

1.23

2.08

1.3

1.4

5.68

1.49

nmol/l

0.38

196

897

Use of galantamine

207

0.43

2.07

1.4

1.2

0.54

0.70

nmol/l

—

192

Benign neoplasm: Liver/bile ducts

2.04

2.07

1.1

1.2

0.49

0.55

nmol/l

0.55

Congenital malformations of genital organs

412

1.45

2.06

1.3

1.2

0.51

0.53

nmol/l

0.31

398

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.35

2.06

1.2

1.3

0.46

0.61

nmol/l

1.29

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.35

2.06

1.2

1.3

0.46

0.54

nmol/l

0.57

Crohn disease (strict definition, require KELA)

277

1.56

2.06

1.5

1.4

0.66

0.59

nmol/l

0.67

266

Crowding of teeth, including avohilmo

260

1.53

2.05

1.2

0.49

0.48

nmol/l

0.06

252

Crohn disease (strict definition, all UC cases excluded)

207

1.65

2.04

1.4

1.3

0.66

0.58

nmol/l

0.63

197

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

278

1.56

2.03

1.3

1.2

0.56

0.63

nmol/l

0.93

266

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

278

1.56

2.03

1.3

0.56

0.65

nmol/l

1.25

265

Endometriosis of intestine

2.53

2.02

1.0

1.1

0.55

0.48

nmol/l

0.69

Benign neoplasm: Vulva

1.98

2.01

1.4

1.2

0.61

0.64

nmol/l

0.13

Benign neoplasm: Other parts of oropharynx

2.86

2.01

1.9

1.3

122.78

0.47

nmol/l

—

Orchitis and epididymitis

319

1.51

2.00

1.2

1.3

0.50

0.62

nmol/l

1.67

307

Diseases of spleen

2.17

1.99

1.5

1.3

0.64

0.57

nmol/l

0.23

Benign neoplasm of other and unspecified sites

126

1.84

1.99

1.3

0.53

0.63

nmol/l

1.19

116

Ulcerative enterocolitis

112

1.89

1.97

1.4

1.3

0.63

0.54

nmol/l

0.49

105

Other and unspecified vasculitis limited to skin

2.05

1.96

1.5

1.2

0.50

0.60

nmol/l

0.99

Other arterial embolism and thrombosis

2.04

1.96

1.2

0.61

0.58

nmol/l

0.18

Lung cancer and mesothelioma

107

700

1.31

1.96

1.1

1.3

0.65

2.73

nmol/l

0.71

101

671

Tonsillectomy and adenotomy

399

2422

1.15

1.94

1.3

0.52

1.27

nmol/l

0.87

383

2345

Acute suppurative otitis media

163

1230

1.24

1.94

1.4

1.3

0.53

0.52

nmol/l

0.15

158

1188

Superficial injury of neck

2.13

1.93

1.1

1.4

0.60

0.50

nmol/l

0.80

Exposure to other and unspecified animate mechanical forces

106

1.90

1.91

1.1

1.3

0.41

0.51

nmol/l

1.27

Foreign body in alimentary tract

196

1.64

1.90

1.4

1.3

0.57

0.63

nmol/l

0.42

185

Kela-code for severe mental illness

251

2123

1.18

1.89

1.2

1.3

0.69

1.90

nmol/l

0.95

237

2051

Abrasion of teeth

185

1114

1.22

1.89

1.2

1.3

0.60

nmol/l

0.01

175

1075

Gastrojejunal ulcer

2.68

1.87

1.0

1.2

0.47

0.51

nmol/l

—

Superficial injury of forearm

407

1.43

1.87

1.3

0.62

0.57

nmol/l

0.32

393

Other mental disorders due to brain damage and dysfunction and to physical disease

449

1.41

1.86

1.5

1.3

0.69

nmol/l

0.00

424

Malignant neoplasm of digestive organs

221

1822

1.20

1.86

1.4

1.3

0.68

2.19

nmol/l

1.04

207

1742

Laparoscopic left hemicolectomy

2.23

1.85

1.1

1.4

0.75

0.58

nmol/l

0.81

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

408

2922

1.14

1.85

1.3

0.61

1.48

nmol/l

0.94

394

2815

Acute appendicitis, with complications

126

997

1.27

1.84

1.1

1.3

0.61

1.96

nmol/l

0.61

115

963

False labour

199

1033

1.21

1.83

1.2

1.3

0.48

1.66

nmol/l

0.54

194

994

Benign neoplasm of other and unspecified sites

130

1.78

1.82

1.3

0.53

0.68

nmol/l

1.55

121

Golimumab

145

1.74

1.82

1.3

0.56

nmol/l

0.02

137

Congenital malformations of the circulatory system

627

1.33

1.82

1.6

1.3

0.57

0.59

nmol/l

0.18

603

Benign neoplasm of thyroid gland

153

1.71

1.80

1.6

1.3

0.63

0.62

nmol/l

0.08

145

Dislocation, sprain and strain of joints and ligaments of thorax

116

1.82

1.79

1.2

1.4

0.71

0.57

nmol/l

0.66

110

Benign neoplasm of ovary

132

1055

1.26

1.79

1.3

0.62

2.11

nmol/l

0.71

125

1019

Other disorders of binocular vision

2.37

1.78

1.5

1.3

0.43

0.45

nmol/l

0.13

Retinal detachments and breaks

221

1861

1.19

1.78

1.3

5.83

0.97

nmol/l

0.45

209

1779

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

315

1865

1.16

1.77

1.3

1.2

3.38

2.04

nmol/l

0.20

298

1788

Benign neoplasm of thyroid gland

154

1.70

1.77

1.6

1.2

0.63

nmol/l

0.01

147

Superficial injuries involving multiple body regions

1.91

1.76

1.1

1.3

0.58

0.52

nmol/l

0.46

Disorders of brain, other and unspecified

2.70

1.73

1.1

1.3

0.79

0.48

nmol/l

—

Ectopic pregnancy

125

997

1.26

1.73

1.3

1.2

0.59

2.15

nmol/l

0.70

118

962

Abnormal findings on diagnostic imaging of breast

2.16

1.73

1.2

0.69

0.67

nmol/l

0.11

Pedal cyclist injured in transport accident

142

1149

1.24

1.73

1.2

1.3

6.49

1.76

nmol/l

0.37

136

1107

Benign neoplasm: Tonsil

2.33

1.72

1.5

1.2

0.60

0.55

nmol/l

0.15

Congenital malformations of the nervous system

1.97

1.70

1.3

0.70

0.48

nmol/l

0.41

Tuberculosis of other organs, strict

1.97

1.70

1.9

1.2

0.69

0.63

nmol/l

0.13

Fall on and from ladder

299

1.48

1.70

1.3

0.57

0.63

nmol/l

0.82

280

Systemic sclerosis, icd10

111

1.82

1.70

1.3

1.2

0.80

0.60

nmol/l

1.09

106

Benign neoplasm: Vulva

104

1.85

1.68

1.4

1.2

0.61

0.63

nmol/l

0.08

Other secondary gonarthrosis

211

1.57

1.68

1.1

1.3

0.55

0.66

nmol/l

1.78

201

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

301

1.47

1.65

1.5

1.4

0.66

0.59

nmol/l

0.59

290

Phlebitis and thrombophlebitis (not including DVT)

145

1185

1.23

1.63

1.2

1.3

0.57

1.93

nmol/l

0.74

139

1146

Premenstrual syndrome

2.53

1.60

1.3

1.2

0.46

0.49

nmol/l

—

Other prurigo

2.23

1.58

1.0

1.3

0.45

0.60

nmol/l

1.54

Benign neoplasm: Tonsil

2.23

1.58

1.5

1.2

0.60

nmol/l

0.01

Vasculitis limited to skin, not elsewhere classified

1.83

1.58

1.4

1.2

0.49

0.61

nmol/l

1.38

Other specified/unspecified necrotizing vasculopathies

2.23

1.58

1.3

0.84

0.53

nmol/l

0.97

Symptoms and signs involving emotional state

1.83

1.58

1.2

1.4

0.55

0.59

nmol/l

0.20

Special screening examination for neoplasms

129

1.71

1.57

1.5

1.2

0.71

0.59

nmol/l

1.13

122

Astigmatism

239

1.51

1.56

1.1

1.3

0.54

0.60

nmol/l

0.85

229

Female infertility

204

1062

1.19

1.56

1.2

1.3

0.53

2.03

nmol/l

0.73

199

1026

Nontoxic diffuse goitre

137

1.69

1.56

1.2

0.53

0.63

nmol/l

1.68

127

Benign neoplasm: Choroid

256

1.49

1.56

1.2

1.3

0.59

0.65

nmol/l

0.46

244

Open wound of shoulder and upper arm

2.05

1.55

1.8

1.4

0.60

0.57

nmol/l

0.09

Other spirochaetal diseases

168

1403

1.20

1.53

1.3

0.58

2.48

nmol/l

1.02

160

1351

Sequelae of injuries of upper limb

467

1.35

1.53

1.5

1.3

0.56

0.62

nmol/l

0.54

449

Other respiratory diseases principally affecting the interstitium

746

1.28

1.53

1.5

1.3

9.81

0.65

nmol/l

0.49

713

Nasal polyp

115

924

1.25

1.53

1.3

0.62

3.68

nmol/l

1.09

109

886

Manic episode

115

1.75

1.53

1.3

0.63

0.61

nmol/l

0.08

109

Malignant immunoproliferative diseases

2.63

1.52

1.1

1.4

0.56

0.48

nmol/l

—

Wilms' tumor, excluding all cancers (controls excluding all cancers)

2.91

1.51

2.2

1.5

0.57

0.48

nmol/l

—

Disorders of eyelid in diseases classified elsewhere

123

1.72

1.51

1.6

1.3

38.60

0.59

nmol/l

0.48

116

Other specified disorders of external ear

123

1.72

1.51

1.3

1.4

0.60

0.66

nmol/l

0.32

115

Need for immunization against other single viral diseases

1.96

1.49

1.4

1.3

0.67

0.56

nmol/l

0.54

Additional codes for the location of defect, injury or illness

234

1.50

1.49

1.1

1.3

0.67

0.66

nmol/l

0.04

222

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

305

1836

1.14

1.49

1.3

1.2

3.48

2.06

nmol/l

0.20

287

1760

Other and unspecified aplastic anaemias

2.47

1.49

1.0

1.2

0.59

0.48

nmol/l

—

Primary open-angle glaucoma

188

1550

1.18

1.49

1.3

0.65

2.38

nmol/l

1.02

175

1476

Macular pucker

670

1.29

1.49

1.1

1.3

0.70

0.66

nmol/l

0.48

641

Primary open-angle glaucoma, strict

154

1278

1.21

1.48

1.3

0.64

1.92

nmol/l

0.74

143

1220

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

292

1.44

1.48

1.4

1.3

0.62

0.64

nmol/l

0.09

279

Type 1 diabetes, definitions combined

443

1.36

1.48

1.7

1.3

0.48

0.51

nmol/l

0.37

429

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

284

1.45

1.47

1.3

0.53

0.58

nmol/l

0.32

272

Lifestyle-related condition

2.25

1.47

1.9

1.2

0.37

0.47

nmol/l

—

Benign neoplasm of other and unspecified intrathoracic organs

2.40

1.46

2.1

1.2

0.67

0.53

nmol/l

—

Maltreatment syndromes

195

1.55

1.45

1.1

1.4

0.56

0.54

nmol/l

0.15

186

Benign neoplasm: Connective and other soft tissue, unspecified

2.15

1.45

1.1

1.3

0.58

0.57

nmol/l

0.03

Nonsuppurative otitis media

135

958

1.22

1.45

1.4

1.3

0.56

0.53

nmol/l

0.56

129

919

Psoriasis vulgaris

117

949

1.24

1.45

1.3

7.77

2.90

nmol/l

0.30

112

916

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.05

1.44

1.2

1.3

0.58

0.61

nmol/l

0.10

Disorder of the sleep-wake schedule

1.99

1.44

1.3

1.4

0.57

0.56

nmol/l

0.04

Psoriasis (vulgaris), strict definition

125

1.69

1.44

1.0

1.3

0.61

nmol/l

0.03

119

Dental caries 3 and operation codes, only avohilmo

240

1036

1.17

1.44

1.3

0.64

2.01

nmol/l

0.69

229

1003

Separation of retinal layers (serosa)

164

1.60

1.43

1.2

1.4

0.63

0.65

nmol/l

0.10

157

LSIL lesion of the vulva

141

1.64

1.42

1.1

1.3

0.44

0.59

nmol/l

2.85

135

Benign neoplasm: Skin of lower limb, including hip

118

1.71

1.42

1.3

0.64

0.61

nmol/l

0.22

112

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

1.83

1.42

1.6

1.2

0.69

0.67

nmol/l

0.08

Chronic lymphocytic leukaemia, helper endpoint

1.83

1.42

1.6

1.2

0.69

0.67

nmol/l

0.08

Benign neoplasm: Liver/bile ducts

103

1.76

1.41

1.1

1.2

0.49

0.56

nmol/l

0.69

Type 1 diabetes, strict (exclude DM2)

439

1.34

1.40

1.7

1.3

0.49

0.51

nmol/l

0.30

424

Unspecified threat to breathing

2.23

1.38

1.2

1.4

0.50

0.53

nmol/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

298

1808

1.14

1.37

1.3

1.2

3.56

2.09

nmol/l

0.21

279

1733

Infections specific to the perinatal period

2.63

1.37

1.2

0.42

0.41

nmol/l

—

Seborrhoeic keratosis

141

1174

1.20

1.37

1.3

6.80

1.98

nmol/l

0.36

131

1127

Open wound of head

318

2776

1.13

1.36

1.2

1.3

1.27

1.62

nmol/l

0.16

303

2675

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

298

1.42

1.35

1.0

1.3

0.61

0.53

nmol/l

0.63

285

Benign neoplasm of other and unspecified intrathoracic organs

2.17

1.34

2.1

1.3

0.67

0.58

nmol/l

—

Organic, including symptomatic, mental disorders

229

1903

0.87

1.34

1.3

0.64

2.14

nmol/l

1.10

211

1815

Bacterial, viral and other infectious agents

375

1.37

1.34

1.6

1.3

0.48

0.59

nmol/l

2.37

362

Anomalies of dental arch relationship, including avohilmo

116

852

1.23

1.33

1.4

1.3

0.53

0.56

nmol/l

0.53

111

825

Second line medication for Crohn's disease

394

3543

1.11

1.32

1.3

0.62

1.39

nmol/l

1.04

378

3407

Coxarthrosis, primary

385

2999

1.12

1.32

1.3

2.86

1.65

nmol/l

0.23

366

2875

Traumatic amputation of wrist and hand

152

1.59

1.32

1.4

0.50

0.65

nmol/l

1.92

144

Benign neoplasm: Liver

1.82

1.32

1.1

1.2

0.49

0.54

nmol/l

0.34

Lesion of lateral popliteal nerve

184

1.53

1.32

1.4

0.59

0.60

nmol/l

0.07

174

Right side

2.55

1.31

1.2

1.4

0.72

0.48

nmol/l

—

Benign neoplasm: Skin of lower limb, including hip

121

1.67

1.31

1.3

0.64

0.68

nmol/l

0.23

113

Tetraplegia

2.53

1.31

1.3

1.2

0.47

0.45

nmol/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

182

1038

1.18

1.30

1.1

1.3

0.54

2.07

nmol/l

0.72

177

1002

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

2.39

1.30

1.1

1.4

0.56

0.53

nmol/l

—

Blindness, monocular

2.39

1.30

1.3

1.4

0.56

0.52

nmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

2.38

1.30

1.1

1.4

0.49

0.45

nmol/l

—

Other protozoal intestinal diseases

1.91

1.29

1.2

1.3

0.58

0.51

nmol/l

0.38

Contusion of other and unspecified parts of foot

193

1.51

1.29

1.2

1.3

0.51

0.58

nmol/l

0.67

184

Benign neoplasm: Connective and other soft tissue, unspecified

2.03

1.28

1.1

1.3

0.58

0.55

nmol/l

0.11

Complications associated with artificial fertilization

2.10

1.28

2.3

1.1

0.49

0.48

nmol/l

—

Fracture at wrist and hand level

214

1856

1.15

1.28

1.3

0.61

2.10

nmol/l

1.06

208

1788

Spontaneous abortion

331

2005

1.12

1.27

1.2

3.07

1.37

nmol/l

0.30

322

1921

Benign neoplasm: Choroid

269

1.42

1.26

1.2

0.59

0.64

nmol/l

0.39

258

Deficiency of other B group vitamins

1.83

1.26

1.1

1.3

0.58

0.57

nmol/l

0.04

Retinal haemorrhage

1.83

1.26

1.1

1.3

0.54

0.63

nmol/l

0.73

Chronic lymphocytic leukaemia

1.75

1.25

1.6

1.3

0.69

0.67

nmol/l

0.08

Female infertility, associated with anovulation

286

1.40

1.25

1.5

1.3

0.44

0.48

nmol/l

0.71

280

ILD, hospital admission 2, with pulmonary infections

346

1.36

1.24

1.5

1.3

20.17

0.64

nmol/l

0.49

336

Unspecified abortion

253

0.59

1.24

1.1

1.3

0.59

5.03

nmol/l

0.49

247

Retinoschisis and retinal cysts

1.78

1.23

1.1

1.2

0.65

0.62

nmol/l

0.08

Osteonecrosis due to drugs

2.07

1.23

1.3

1.4

0.51

0.55

nmol/l

—

Other and unspecified paralytic syndromes

1.99

1.23

1.5

1.3

0.42

0.55

nmol/l

0.96

Purpura and other haemorrhagic conditions

610

1.27

1.22

1.4

1.3

0.62

0.63

nmol/l

0.03

582

Strabismus

162

1381

1.17

1.21

1.3

5.69

1.71

nmol/l

0.35

157

1333

L04AX Other immunosuppressants

383

3460

1.11

1.21

1.3

0.62

1.41

nmol/l

1.05

367

3328

Maternal care for cervical incompetence

205

1.47

1.20

1.1

1.3

0.59

0.64

nmol/l

0.46

197

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

1.85

1.20

2.2

1.3

0.54

0.65

nmol/l

0.85

Open wound of wrist and hand

272

2388

1.13

1.20

1.3

0.53

1.83

nmol/l

1.25

267

2298

Perichondritis of external ear

1.89

1.18

1.2

1.3

0.54

0.59

nmol/l

0.21

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.89

1.18

1.2

1.3

0.57

0.54

nmol/l

0.11

Cerebral atherosclerosis

2.12

1.18

1.4

1.3

0.86

0.51

nmol/l

—

Fall on and from stairs and steps

153

1304

1.18

1.3

0.59

1.81

nmol/l

0.72

145

1254

Endometriosis of rectovaginal septum and vagina

393

1.33

1.17

1.1

1.2

0.56

4.57

nmol/l

0.71

379

Guillain-Barre syndrome

1.95

1.17

1.4

0.56

0.53

nmol/l

0.16

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

1.95

1.17

2.4

1.2

0.50

0.64

nmol/l

1.09

Noise effects on inner ear

133

1.59

1.17

1.2

1.4

0.55

0.62

nmol/l

0.30

127

Lymphoid leukaemia

198

1.47

1.17

1.6

1.3

0.62

0.65

nmol/l

0.16

186

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

199

1.46

1.14

1.4

1.3

0.65

0.66

nmol/l

0.03

189

Lymphoid leukaemia

199

1.46

1.14

1.6

1.3

0.62

0.65

nmol/l

0.15

190

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

698

4221

1.08

1.14

1.3

0.64

1.51

nmol/l

1.36

667

4074

Labour and delivery complicated by umbilical cord complications

216

1.44

1.13

1.1

1.3

0.57

0.56

nmol/l

0.06

208

Type 1 diabetes, strict definition, subgroup 1

317

1.36

1.13

1.1

1.2

0.47

0.48

nmol/l

0.17

310

Adult respiratory distress syndrome

2.02

1.12

1.3

0.49

0.50

nmol/l

—

therapeutic use

119

1.61

1.12

1.0

1.3

0.65

0.66

nmol/l

0.03

110

Benign neoplasm: Liver

1.72

1.12

1.1

1.2

0.49

0.56

nmol/l

0.53

Other vitreous opacities

143

1.55

1.11

1.1

1.2

0.52

0.65

nmol/l

1.76

133

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

1.80

1.11

2.0

1.2

0.92

0.65

nmol/l

0.51

Malignant melanoma

681

1.24

1.11

1.2

1.3

0.67

0.65

nmol/l

0.19

651

Lyme disease

161

1387

1.16

1.11

1.3

0.58

2.50

nmol/l

1.02

153

1336

Other disorders of veins

266

2371

1.12

1.09

1.3

0.62

1.72

nmol/l

0.99

256

2286

Sulfasalazine

185

1613

1.15

1.08

1.2

1.3

0.66

2.34

nmol/l

1.03

175

1553

Other melanin hyperpigmentation

1.70

1.08

1.5

1.2

0.69

0.63

nmol/l

0.30

Multiple delivery

467

0.73

1.08

1.2

1.3

0.64

1.48

nmol/l

0.46

449

Lichen planus, including avohilmo

117

986

1.19

1.06

1.3

0.65

2.21

nmol/l

0.69

110

951

Malignant immunoproliferative diseases

2.15

1.06

1.1

1.4

0.56

0.55

nmol/l

—

Fracture of forearm

380

3240

1.10

1.06

1.3

0.62

1.73

nmol/l

1.33

356

3130

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

1.72

1.05

2.1

1.3

0.54

0.67

nmol/l

0.96

Oral leukoplakia

1.81

1.05

1.2

1.3

0.58

0.56

nmol/l

0.08

Contraceptive management

234

1853

0.89

1.05

1.3

0.55

1.53

nmol/l

0.86

225

1795

Inguinal hernia

373

2285

1.10

1.04

1.4

1.3

0.59

1.90

nmol/l

1.19

357

2213

Opening and dilatation of root channel of tooth

271

1.37

1.04

1.1

1.3

0.59

0.63

nmol/l

0.27

259

Use of cabergoline

1.97

1.04

1.1

1.3

0.57

0.50

nmol/l

—

Sequelae of other accidents

1.97

1.04

1.2

0.48

0.52

nmol/l

—

Sequelae of tuberculosis

1.97

1.04

1.2

1.4

0.51

0.58

nmol/l

—

Optic atrophy

1.85

1.03

1.5

1.3

0.45

0.56

nmol/l

0.84

Injury of urinary and pelvic organs

1.75

1.03

1.8

1.3

0.56

0.59

nmol/l

0.16

Allergic purpura

114

1.59

1.03

1.1

1.3

0.49

0.55

nmol/l

0.48

105

Malignant neoplasm of tonsil

1.93

1.02

2.7

1.3

0.54

0.60

nmol/l

—

Traumatic ischaemia of muscle

1.93

1.02

2.0

1.3

0.72

0.46

nmol/l

—

Chronic myeloproliferative disease

1.91

1.02

1.1

1.3

0.63

0.54

nmol/l

—

Hereditary retinal dystrophy

1.90

1.02

1.0

1.3

0.49

0.53

nmol/l

—

Malignant neoplasm of prostate

187

1032

1.15

1.01

1.4

1.3

0.67

1.84

nmol/l

0.59

179

989

Alcoholic liver disease

395

1.30

1.00

1.5

1.3

0.71

0.64

nmol/l

0.48

374

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

122

1020

1.18

1.00

1.2

0.64

2.20

nmol/l

0.71

117

970

Lung diseases due to external agents

537

1.25

1.00

1.5

1.3

0.63

0.65

nmol/l

0.16

515

Alopecia areata

107

1.60

1.00

1.2

1.3

0.59

0.57

nmol/l

0.11

102

Chondromalacia

115

1.57

1.00

1.1

1.3

0.74

0.59

nmol/l

0.26

107

Malignant melanoma of skin

511

1.26

0.99

1.2

1.3

0.68

0.64

nmol/l

0.32

486

Personal history of allergy to drugs, medicaments and biological substances

1.86

0.99

1.1

1.3

0.48

0.52

nmol/l

—

Other and unspecified vaccines and biological substances

2.20

0.98

1.2

0.42

0.45

nmol/l

—

Benign neoplasm: Skin of scalp and neck

1.64

0.97

1.2

1.3

0.55

nmol/l

0.04

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

1.96

0.97

1.1

1.4

0.74

0.62

nmol/l

—

Microscopic polyangiitis

0.00

0.97

0.0

1.2

—

0.46

—

Other interventions on the root canals of the tooth

1.75

0.97

1.2

1.4

0.64

0.54

nmol/l

0.57

Congenital malformations of ovaries, fallopian tubes and broad ligaments

241

1.37

0.96

1.2

0.54

0.57

nmol/l

0.25

234

Other and unspecified injuries of wrist and hand

149

1.48

0.95

1.2

1.3

0.54

0.64

nmol/l

0.52

142

Other maternal disorders predominantly related to pregnancy

416

2401

1.09

0.95

1.2

1.3

0.55

1.24

nmol/l

0.77

399

2319

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

149

1.48

0.95

1.5

1.2

0.63

0.68

nmol/l

0.25

141

Other degenerative diseases of the basal ganglia

1.78

0.95

1.0

1.3

0.58

0.57

nmol/l

—

Malignant neoplasm of oropharynx

1.78

0.95

2.7

1.3

0.54

0.60

nmol/l

—

Erythema nodosum

133

1.51

0.94

1.4

1.3

0.54

0.61

nmol/l

0.46

127

Disorder of external ear, unspecified

117

1.55

0.94

1.1

1.3

0.61

0.62

nmol/l

0.06

111

Benign neoplasm: other/unspecified salivary gland

101

1.59

0.94

1.4

1.2

0.71

0.63

nmol/l

0.26

ILD, hospital admissions

615

1.22

0.93

1.5

1.3

12.23

0.66

nmol/l

0.49

586

Malignant neoplasm of skin

391

2702

1.09

0.93

1.3

2.88

1.68

nmol/l

0.22

367

2587

Toxic liver disease

1.83

0.92

1.2

1.3

0.60

nmol/l

—

Type 1 diabetes, strict definition

338

1.30

0.92

1.1

1.2

0.46

0.49

nmol/l

0.29

331

Impetigo

167

1.44

0.92

1.3

0.61

0.59

nmol/l

0.16

159

Obstructed labour due to maternal pelvic abnormality

941

0.83

0.92

1.3

0.62

2.25

nmol/l

0.69

912

Sequelae of poliomyelitis

2.17

0.92

1.0

1.4

1.08

0.51

nmol/l

—

Endometriosis of fallopian tube

2.17

0.92

1.2

0.48

0.57

nmol/l

—

Superficial injury of hip and thigh

607

1.22

0.92

1.3

0.60

0.65

nmol/l

0.65

577

Benign neoplasm: Lip

1.64

0.91

1.0

1.2

0.63

0.59

nmol/l

0.15

Lesion of sciatic nerve

159

1.45

0.91

1.2

1.3

0.62

0.66

nmol/l

0.16

149

Burn and corrosion of trunk

102

1.58

0.90

1.1

1.3

0.58

0.59

nmol/l

0.05

Interstitial lung disease endpoints

618

1.22

0.90

1.5

1.3

12.23

0.66

nmol/l

0.49

589

Other interstitial pulmonary diseases

618

1.22

0.90

1.5

1.3

12.23

0.66

nmol/l

0.49

589

Interstitial lung disease

618

1.22

0.90

1.5

1.3

12.23

0.66

nmol/l

0.49

589

malignant neoplasm of male genital organs

193

1085

1.13

0.89

1.4

1.3

0.67

1.77

nmol/l

0.59

185

1041

Horner syndrome

1.92

0.89

1.6

1.3

0.62

0.48

nmol/l

—

Disorders of speech understanding and production

141

1.47

0.88

1.3

1.2

0.53

0.50

nmol/l

0.26

132

Premature separation of placenta [abruptio placentae]

1.62

0.88

1.1

1.2

0.47

0.51

nmol/l

0.34

Lichen planus

657

1.21

0.87

1.3

0.65

3.01

nmol/l

0.69

632

Injury of muscle and tendon at lower leg level

703

1.20

0.87

1.2

1.3

0.60

0.90

nmol/l

0.51

674

Lesion of radial nerve

136

1.48

0.86

1.3

1.4

0.67

0.66

nmol/l

0.04

127

Reactive arthropathies, FINNGEN

308

1.30

0.85

1.2

1.3

0.60

0.59

nmol/l

0.04

295

Osteitis due to dental implant

1.96

0.85

1.0

1.4

0.48

0.49

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.64

0.85

1.6

1.3

0.72

0.59

nmol/l

0.98

Focal brain injury

204

1.38

0.85

1.0

1.3

0.63

0.64

nmol/l

0.07

194

Benign neoplasm: Skin of scalp and neck

1.57

0.84

1.2

1.3

0.55

0.62

nmol/l

0.47

Unspecified event, undetermined intent

1.57

0.84

1.4

1.3

0.45

0.58

nmol/l

0.90

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

1.77

0.84

1.5

1.3

0.58

0.60

nmol/l

—

Other noninflammatory disorders of cervix uteri

248

1.34

0.83

1.3

1.2

0.61

6.90

nmol/l

0.70

240

Sixth [abducent] nerve palsy

121

1.50

0.83

1.1

1.3

0.69

0.64

nmol/l

0.29

113

Other and unspecified psoriasis

275

1.31

0.82

1.5

1.3

0.64

nmol/l

0.03

262

Dental caries 2 and operation codes, only avohilmo

459

3062

0.93

0.82

1.2

1.3

0.57

1.34

nmol/l

1.05

442

2945

Benign neoplasm of major salivary glands

426

1.25

0.82

1.2

1.3

0.68

0.64

nmol/l

0.34

409

Injury of nerves and spinal cord at neck level

1.65

0.82

1.2

0.59

0.58

nmol/l

0.03

Benign neoplasm: Lip

1.58

0.81

1.0

1.2

0.63

0.64

nmol/l

0.05

Other osteochondropathies

293

1.30

0.81

1.1

1.3

0.61

0.60

nmol/l

0.05

280

Convalescence

241

1.33

0.80

1.2

1.3

0.52

0.66

nmol/l

2.32

233

Malignant neoplasm of breast, HER2-negative

308

2466

0.92

0.79

1.3

1.2

3.32

1.27

nmol/l

0.35

299

2369

Benign neoplasm: Orbit, unspecified

0.00

0.79

0.0

1.4

—

0.44

—

Benign neoplasm: other/unspecified salivary gland

106

1.52

0.79

1.4

1.2

0.71

0.67

nmol/l

0.11

Certolizumab pegol

1.68

0.79

1.2

0.52

0.48

nmol/l

0.24

Moderate visual impairment, binocular

1.56

0.78

1.2

0.69

0.61

nmol/l

0.46

Benign neoplasm of other and unspecified female genital organs

234

1.33

0.78

1.5

1.2

0.63

0.65

nmol/l

0.21

224

Bicuspidal aortic valve syndrome

140

1.44

0.77

1.1

1.4

0.53

0.62

nmol/l

0.76

133

Uterine polyps

512

1.21

0.76

1.1

1.2

0.57

3.64

nmol/l

0.72

498

Other and unspecified haemorrhagic conditions

1.71

0.75

1.2

0.87

0.50

nmol/l

—

Habitual aborter

1.71

0.75

1.3

1.1

0.68

0.46

nmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

1.65

0.75

1.2

1.3

0.72

0.56

nmol/l

0.48

Other renal tubulo-interstitial diseases

1.55

0.75

1.1

1.3

0.66

0.56

nmol/l

0.60

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

106

765

1.16

0.75

1.2

1.3

0.65

4.06

nmol/l

0.98

100

733

Other specific arthropathies, wide

1.58

0.75

1.2

1.3

0.45

0.58

nmol/l

0.89

Malignant neoplasm, without specification of site

1.57

0.75

1.5

1.3

0.62

nmol/l

0.02

Seropositive rheumatoid arthritis

156

1385

1.13

0.75

1.3

0.65

2.23

nmol/l

0.80

147

1327

Polyarteritis nodosa and related conditions

1.68

0.75

1.7

1.3

0.51

0.52

nmol/l

—

Complications of labour and delivery

413

2474

0.93

0.74

1.2

1.3

2.56

1.23

nmol/l

0.29

405

2379

Dependence on enabling machines and devices, not elsewhere classified

1.85

0.73

1.0

1.4

0.51

0.50

nmol/l

—

Malignant neoplasm of breast

319

2492

0.92

0.73

1.3

1.2

3.22

1.26

nmol/l

0.34

310

2394

Increased muscle tone

2.02

0.73

1.0

1.4

0.26

0.44

nmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.59

0.71

1.2

0.63

0.53

nmol/l

—

Colorectal cancer

122

1074

1.14

0.71

1.3

0.61

2.71

nmol/l

0.83

114

1025

Basal cell carcinoma, including avohilmo

347

2535

1.08

0.70

1.3

3.15

1.76

nmol/l

0.23

326

2422

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

121

892

1.14

0.70

1.2

0.66

3.58

nmol/l

0.98

115

852

Other/unspecified reactive arthropathies

274

1.28

0.69

1.2

1.3

0.62

nmol/l

0.04

260

Superficial injury of thorax

693

1.17

0.69

1.2

1.3

0.62

0.61

nmol/l

0.16

669

Benign neoplasm of other and unspecified female genital organs

239

1.30

0.69

1.5

1.2

0.63

nmol/l

0.02

230

Benign neoplasm: Skin of upper limb, including shoulder

1.54

0.69

1.6

1.3

0.72

0.61

nmol/l

0.89

Other and unspecified nail disorders

1.57

0.69

1.1

1.3

0.66

0.61

nmol/l

0.19

Generalized epilepsy

161

1.37

0.68

1.2

1.3

0.55

0.58

nmol/l

0.21

154

ILD, hospital admissions 1, main diag only

556

1.19

0.68

1.6

1.3

13.75

0.66

nmol/l

0.49

529

Basal cell carcinoma

336

2485

1.08

0.68

1.3

3.23

1.79

nmol/l

0.24

315

2374

Other and unspecified iridocyclitis

170

1.36

0.67

1.2

1.3

0.64

0.61

nmol/l

0.11

160

LSIL lesion of the cervix uteri, vagina or vulva

714

1.16

0.67

1.2

0.47

2.16

nmol/l

0.54

692

Deep endometriosis

511

1.20

0.67

1.1

1.2

0.56

0.60

nmol/l

0.55

494

Malignant neoplasm of colon

640

1.17

0.67

1.4

1.3

0.59

0.66

nmol/l

1.15

608

Keratoconus

0.54

0.67

1.0

1.4

0.52

0.63

nmol/l

—

Postzoster neuralgia

1.64

0.67

1.1

1.3

0.56

0.62

nmol/l

—

Varicose veins

428

3030

1.07

0.67

1.2

1.3

0.69

1.82

nmol/l

1.23

404

2914

Crystalline deposits in vitreous body

1.80

0.66

1.0

1.4

0.54

0.56

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

328

2405

1.08

0.66

1.3

3.29

1.82

nmol/l

0.23

309

2298

Rare circulating lymphoid malignancy

1.52

0.66

1.6

1.3

0.49

0.54

nmol/l

0.40

Lichen ruber planus, wide definition including periferal and oral lichen planus

133

1186

1.12

0.65

1.4

1.3

0.64

1.95

nmol/l

0.69

126

1140

Type1 diabetes, definitions combined, early onset

276

1.27

0.65

1.6

1.3

0.42

0.49

nmol/l

0.97

268

Dental caries 1 and operation codes, only avohilmo

197

899

1.10

0.63

1.3

0.66

2.23

nmol/l

0.69

187

866

Septal defects

246

1.28

0.63

2.2

1.3

0.60

0.59

nmol/l

0.09

234

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

1.53

0.62

1.3

1.2

1.97

0.64

nmol/l

0.50

Tubulo-interstitial nephritis, not specified as acute or chronic

270

1.26

0.62

1.1

1.3

0.63

0.62

nmol/l

0.07

257

Embolic stroke

138

1.38

0.62

1.4

1.2

0.61

0.66

nmol/l

0.26

128

Benign neoplasm: Spinal meninges

1.61

0.61

2.0

1.3

1.51

0.64

nmol/l

—

Corneal scars and opacities

1.47

0.61

1.3

1.2

0.59

0.58

nmol/l

0.01

Benign neoplasm: Bronchus and lung

1.61

0.61

1.0

1.3

0.56

0.53

nmol/l

—

Anomalies of pupillary function

1.49

0.61

1.3

1.4

0.50

0.53

nmol/l

0.22

Hereditary corneal dystrophies

138

0.65

0.61

1.1

1.2

0.54

0.63

nmol/l

—

129

Family history of other conditions

1.58

0.60

2.8

1.3

0.36

0.47

nmol/l

—

Nystagmus and other irregular eye movements

1.55

0.59

1.1

1.3

0.65

0.48

nmol/l

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

1.57

0.58

1.2

1.1

0.72

0.64

nmol/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

182

1616

0.91

0.58

1.4

1.2

5.17

1.60

nmol/l

0.36

176

1549

Shoulder region

1.49

0.57

1.0

1.3

0.49

0.51

nmol/l

—

Mental retardation

132

1.37

0.57

1.2

1.3

0.55

0.59

nmol/l

0.18

126

Car occupant injured in noncollision transport accident

141

1.35

0.56

1.2

1.3

0.51

0.57

nmol/l

0.59

133

Gestational diabetes (for exclusion)

215

1402

1.09

0.55

1.2

1.3

0.47

1.35

nmol/l

0.56

207

1360

!Aliquae complicationes praecoces traumatis

159

1.33

0.55

1.6

1.3

0.61

0.59

nmol/l

0.08

149

Early complications of trauma

159

1.33

0.55

1.6

1.3

0.61

0.59

nmol/l

0.08

149

Contact with venomous snakes and lizards

1.59

0.54

1.0

1.4

0.40

0.45

nmol/l

—

Other injuries of upper limb, level unspecified

1.59

0.54

1.2

0.77

0.46

nmol/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.49

0.54

1.1

0.51

0.44

nmol/l

—

Other autoimmune haemolytic anaemias

1.55

0.53

1.3

1.4

0.47

0.56

nmol/l

—

Adhesive middle ear disease

1.46

0.53

1.3

0.70

0.54

nmol/l

—

Malnutrition

1.52

0.52

2.0

1.3

0.66

0.56

nmol/l

—

Pregnancy, childbirth and the puerperium

193

928

1.09

0.52

1.2

1.3

0.64

1.09

nmol/l

0.48

186

874

Other and unspecified mononeuropathies of upper limb

126

1.35

0.51

1.4

0.58

0.61

nmol/l

0.13

117

Congenital malformations of cardiac septa

260

1.23

0.51

2.2

1.3

0.59

0.58

nmol/l

0.06

248

Systemic atrophies primarily affecting the central nervous system

145

0.69

0.50

1.1

1.2

0.74

0.61

nmol/l

—

136

Dysplasia of cervi uteri

140

985

1.10

0.50

1.2

1.3

0.49

2.15

nmol/l

0.75

134

951

Failed attempted abortion

1.47

0.50

1.0

1.1

0.65

0.44

nmol/l

—

Otosclerosis

380

1.19

0.50

1.5

1.3

0.78

0.66

nmol/l

0.60

363

Complications following abortion and ectopic and molar pregnancy

189

1.27

0.49

1.1

1.3

0.66

0.64

nmol/l

0.16

180

Disorders of globe

1.43

0.49

1.6

1.4

0.57

0.67

nmol/l

0.58

Mild mental retardation

1.43

0.49

1.2

1.3

0.62

0.56

nmol/l

0.18

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

464

1.17

0.49

1.4

1.3

0.63

0.66

nmol/l

0.30

445

Other and unspecified acne

1.56

0.49

1.0

1.4

0.26

0.48

nmol/l

—

Benign neoplasm: Skin of trunk

172

1.28

0.48

1.4

1.3

0.69

0.62

nmol/l

0.46

161

Right hemicolectomy

235

1.24

0.48

1.3

0.69

nmol/l

0.04

219

Other acute viral hepatitis

1.50

0.47

1.6

1.3

0.63

0.51

nmol/l

—

Other/unspecified cytomegaloviral diseases

1.48

0.47

1.3

1.2

0.45

0.55

nmol/l

—

Non-Hodgkin lymphoma, all

120

1.34

0.46

1.2

0.82

0.64

nmol/l

0.39

110

Obstructive hydrocephalus

1.43

0.46

1.4

1.3

0.54

0.48

nmol/l

—

Sequelae of infectious and parasitic diseases

328

1.19

0.46

1.1

1.3

0.67

0.60

nmol/l

0.57

315

Hepatocellular carcinoma

1.43

0.46

1.4

1.3

2.84

0.60

nmol/l

—

Other intracranial haemorrhages

1.39

0.46

1.5

1.2

0.68

0.64

nmol/l

0.20

Overjet

0.60

0.46

1.0

1.2

0.42

0.44

nmol/l

—

Fracture of shoulder and upper arm

211

1967

1.07

0.45

1.3

2.60

1.85

nmol/l

0.14

202

1881

Inguinal of femoral hernia, unilateral

103

1.36

0.45

1.4

1.3

0.66

0.64

nmol/l

0.12

Femoral hernia, unilateral

103

1.36

0.45

1.4

1.3

0.66

0.64

nmol/l

0.12

Inguinal hernia, unilateral

103

1.36

0.45

1.4

1.3

0.66

0.64

nmol/l

0.12

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

164

0.73

0.45

1.4

1.3

0.57

0.68

nmol/l

0.68

154

Benign neoplasm: Skin of trunk

174

1.27

0.45

1.4

1.3

0.69

0.64

nmol/l

0.29

163

Melanocytic naevi of lower limb, including hip

174

1.27

0.45

1.4

1.3

0.58

0.64

nmol/l

0.35

164

Melanocytic naevi of lower limb, including hip

174

1.27

0.45

1.4

1.3

0.58

0.60

nmol/l

0.10

164

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

817

1.11

0.45

1.3

1.2

0.63

3.84

nmol/l

0.99

783

Late syphilis

1.38

0.44

1.3

1.2

0.34

0.52

nmol/l

—

Other secondary coxarthrosis

148

1.29

0.43

1.6

1.3

0.72

0.62

nmol/l

0.40

141

Other deformities of toe(s)

157

1.28

0.43

1.2

1.3

0.66

0.63

nmol/l

0.19

150

Emergency coronary revascularization (for ACS)

274

2088

0.94

0.43

1.3

4.53

1.49

nmol/l

0.37

264

1994

Rubella [German measles]

131

0.68

0.43

1.1

1.4

0.61

nmol/l

—

126

Unspecified urinary incontinence

424

1.16

0.42

1.2

1.3

0.63

0.64

nmol/l

0.14

404

Open wound of lower leg

669

1.12

0.42

1.3

0.60

0.61

nmol/l

0.08

639

Post-traumatic wound infection, not elsewhere classified

1.38

0.42

1.2

1.3

0.52

0.58

nmol/l

0.36

Benign neoplasm of major salivary glands

462

1.15

0.42

1.2

1.3

0.68

0.64

nmol/l

0.34

440

Congenital malformations of aortic and mitral valves

158

1.27

0.42

1.1

1.3

0.52

0.61

nmol/l

0.65

151

Chronic Coagulation defects

1.36

0.41

1.3

0.65

0.52

nmol/l

1.04

Severe visual impairment, monocular

1.52

0.41

1.2

1.4

0.58

0.53

nmol/l

—

Molar incisor enamel hypoplasia, with caries

0.00

0.41

0.0

1.2

—

0.48

—

L01XE Protein kinase inhibitors

239

0.79

0.41

1.3

1.2

0.65

0.66

nmol/l

0.04

224

Hypoplasia of dental enamel, including avohilmo

0.00

0.41

0.0

1.2

—

0.50

—

Other congenital malformations of intestine

1.48

0.40

2.4

1.3

0.46

0.47

nmol/l

—

ILD, hospital admissions 3, with pneumonia sepsis

296

1.18

0.40

1.7

1.3

28.25

0.68

nmol/l

0.49

285

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

1.34

0.40

1.3

1.5

0.48

0.63

nmol/l

—

Diabetic retinopathy, strict definition

118

950

1.09

0.40

1.3

1.4

9.48

1.30

nmol/l

0.45

113

917

Colon adenocarcinoma

474

1.14

0.40

1.4

1.3

0.63

0.67

nmol/l

0.41

449

Iridocyclitis in diseases classified elsewhere

1.37

0.38

1.4

1.3

0.56

0.58

nmol/l

—

Maternal care for known or suspected fetal abnormality and damage

657

0.89

0.38

1.5

1.3

0.45

0.51

nmol/l

1.49

635

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

1.40

0.38

1.0

1.2

0.80

0.54

nmol/l

—

Mesothelioma

1.39

0.38

1.0

1.2

0.62

0.52

nmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

170

1579

1.07

0.37

1.2

1.3

0.50

1.53

nmol/l

0.76

164

1530

Left ventricular outflow tract obstruction, narrow definition

179

1.23

0.37

1.0

1.4

0.51

0.60

nmol/l

0.86

171

Malignant neoplasm of ovary

246

0.81

0.37

1.1

1.2

0.67

0.65

nmol/l

0.06

234

Abnormal findings in secretions and smears from cervix uteri vagina vulva

324

2426

1.05

0.37

1.2

1.3

0.60

1.22

nmol/l

0.66

312

2341

Beningn neoplasm: Meninges, unspecified

1.27

0.36

1.1

1.2

0.53

0.63

nmol/l

—

Chronic ulcer of skin, not elsewhere classified

272

1.18

0.36

1.5

1.3

0.65

0.67

nmol/l

0.08

258

Carcinoma in situ of breast, other/unspecified

0.65

0.36

1.4

1.2

0.46

0.70

nmol/l

—

Myeloid leukaemia

1.34

0.36

1.4

1.3

0.48

0.61

nmol/l

1.17

Femoral hernia

171

1.23

0.35

1.2

0.61

0.67

nmol/l

0.36

160

Contusion of toe(s) with damage to nail

1.43

0.35

1.2

1.3

0.67

0.48

nmol/l

—

Thrombocytopenia, unspecified

282

1.17

0.35

1.7

1.3

0.68

0.64

nmol/l

0.13

267

Generalized epilepsy, mode (most common among epilepsy diagnosis)

117

1.29

0.35

1.2

1.3

0.58

0.57

nmol/l

0.06

110

Other diseases of appendix

1.40

0.35

1.0

1.2

0.50

0.57

nmol/l

—

Abscess of lung

1.37

0.34

1.2

1.3

0.83

0.59

nmol/l

—

Multiple myeloma and malignant plasma cell neoplasms

178

0.78

0.34

1.3

1.2

0.71

0.67

nmol/l

0.14

168

Multiple myeloma, excluding all cancers (controls excluding all cancers)

178

0.78

0.34

1.3

1.2

0.71

0.67

nmol/l

0.14

168

Cholesteatoma of middle ear

200

1.20

0.33

1.3

0.71

0.64

nmol/l

0.51

189

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

100

1.30

0.33

1.6

1.2

0.49

0.64

nmol/l

1.73

Primary coxarthrosis, bilateral

160

1502

1.07

0.33

1.3

0.66

2.42

nmol/l

0.99

152

1436

Prolapse and hernia of ovary and fallopian tube

164

0.78

0.32

1.2

0.75

0.73

nmol/l

0.08

150

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1.28

0.32

2.5

1.3

0.48

0.54

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

137

1.24

0.32

1.3

1.48

0.65

nmol/l

0.44

128

Mental retardation, wide definition

146

1.23

0.32

1.2

1.3

0.55

0.60

nmol/l

0.23

139

Secondary parkinsonism

1.31

0.32

1.3

0.74

0.63

nmol/l

0.43

Secondary parkinsonism+Parkinsonism in other disease

1.31

0.32

1.3

0.74

0.63

nmol/l

0.43

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

1.35

0.31

1.9

1.2

2.97

0.61

nmol/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.35

0.31

1.3

1.2

0.70

0.54

nmol/l

—

Chronic hepatitis NAS

1.33

0.31

1.0

1.2

0.61

0.56

nmol/l

—

Contact with other hot metals

1.32

0.31

1.4

0.76

0.51

nmol/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

153

0.78

0.30

1.4

1.3

0.58

0.65

nmol/l

0.47

143

Filling of root of tooth

129

1.24

0.30

1.0

1.3

0.69

0.61

nmol/l

0.52

121

Peripheral retinal degeneration

120

1.25

0.30

1.3

1.4

0.49

0.62

nmol/l

0.98

113

Myeloid leukaemia

1.29

0.30

1.4

1.3

0.48

0.67

nmol/l

1.79

Multiple myeloma and malignant plasma cell neoplasms

174

0.80

0.29

1.3

1.2

0.71

0.64

nmol/l

0.31

163

Hodgkin lymphoma, hilmo

108

0.74

0.29

1.3

1.4

0.56

0.58

nmol/l

—

100

Follow-up care involving plastic surgery

184

0.81

0.28

1.2

1.3

0.65

0.63

nmol/l

0.06

178

Amputation of foot

1.32

0.28

1.4

1.2

0.60

0.56

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

1.30

0.28

1.4

1.2

2.05

0.62

nmol/l

0.50

Other meningitis

1.27

0.28

1.4

1.2

0.55

0.49

nmol/l

—

Foreign body in respiratory tract

214

1.17

0.28

1.2

0.50

0.62

nmol/l

1.62

205

Persons encountering health services in circumstances related to reproduction

390

2551

1.04

0.27

1.6

1.3

0.54

1.28

nmol/l

0.90

378

2471

Toxic effect of carbon monoxide

1.25

0.27

1.5

1.3

0.51

0.52

nmol/l

—

Other and unspecified injuries of thorax

1.23

0.27

1.0

1.2

0.59

0.54

nmol/l

—

Carcinoma in situ of skin of scalp and neck

1.23

0.27

1.6

1.2

0.73

0.61

nmol/l

—

Anisometropia and aniseikonia

122

1.23

0.27

1.5

1.2

54.05

0.57

nmol/l

0.48

116

Left hemicolectomy

1.28

0.26

1.5

1.3

0.61

0.62

nmol/l

0.04

Carcinoma in situ of breast, other/unspecified

0.68

0.26

1.4

1.2

0.46

0.68

nmol/l

—

Malignant neoplasm of eye, brain and central nervous system

171

0.82

0.26

1.6

1.4

0.78

0.63

nmol/l

0.22

160

Orthopaedic devices associated with adverse incidents

1.22

0.25

1.0

1.2

0.68

0.62

nmol/l

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

114

1.23

0.25

1.3

1.2

0.64

0.65

nmol/l

0.09

107

Beningn neoplasm: Meninges, unspecified

1.20

0.25

1.1

1.3

0.53

0.63

nmol/l

—

Open wound of abdomen, lower back and pelvis

105

1.24

0.25

1.2

1.4

0.54

0.62

nmol/l

0.42

Carcinoma in situ of skin of trunk

1.25

0.24

2.4

1.2

0.88

0.63

nmol/l

1.02

Carcinoma in situ of skin of trunk

1.25

0.24

2.4

1.2

0.88

0.65

nmol/l

0.96

Vascular dementia (undefined)

1.17

0.24

1.2

1.3

0.67

0.69

nmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

407

1.11

0.24

1.2

1.3

0.68

0.64

nmol/l

0.25

388

Other superficial mycoses

1.29

0.24

2.3

1.3

0.60

0.57

nmol/l

—

Chronic suppurative otitis media, including avohilmo

331

1.12

0.24

1.2

1.3

0.58

0.63

nmol/l

0.67

316

Intentional self-harm by sharp object

0.70

0.24

1.5

1.3

0.82

0.52

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

208

1.16

0.24

1.3

1.25

0.66

nmol/l

0.44

199

Cirrhosis of liver, NAS

180

1.17

0.23

1.4

1.3

0.84

0.64

nmol/l

0.89

171

Congenital malformations of gallbladder, bile ducts and liver

1.32

0.23

1.6

1.4

0.48

0.56

nmol/l

—

Prurigo nodularis

106

1.23

0.23

1.5

1.2

0.55

0.60

nmol/l

0.32

Coronary artery bypass grafting

110

888

0.94

0.23

1.2

1.3

0.72

0.85

nmol/l

0.31

105

841

LSIL lesion of the cervix uteri

524

1.09

0.23

1.2

1.3

0.47

0.54

nmol/l

1.60

510

1.29

0.23

1.2

1.3

0.48

0.47

nmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.29

0.23

2.2

1.3

0.74

0.60

nmol/l

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

1.25

0.22

1.4

1.2

0.71

0.69

nmol/l

0.12

Carcinoma in situ of skin, other sites/unspecified

1.25

0.22

1.4

1.2

0.70

0.54

nmol/l

—

Carcinoma in situ of skin, other sites/unspecified

1.25

0.22

1.4

1.2

0.70

0.55

nmol/l

—

Atypical virus infections of central nervous system

1.22

0.22

1.0

1.3

0.50

0.53

nmol/l

—

Pedestrian injured in other and unspecified transport accidents

1.22

0.22

1.6

1.4

1.14

0.51

nmol/l

—

Mesothelioma, excluding all cancers (controls excluding all cancers)

1.22

0.22

1.0

1.2

0.62

0.59

nmol/l

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

178

0.84

0.22

1.5

1.2

0.77

0.65

nmol/l

0.23

168

Diffuse large B-cell lymphoma, helper endpoint

178

0.84

0.22

1.5

1.2

0.77

0.65

nmol/l

0.23

168

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.1

—

0.42

—

Acanthosis nigricans

0.00

0.21

0.0

1.2

—

0.48

—

Hodgkin lymphoma

103

0.78

0.21

1.3

0.56

0.61

nmol/l

—

Schizophrenia or delusion

187

1795

1.04

0.21

1.3

0.66

2.13

nmol/l

1.00

174

1736

Melanoma in situ of trunk

1.16

0.21

1.4

1.2

0.66

0.51

nmol/l

—

Schizophrenia

822

0.94

0.21

1.3

0.78

1.97

nmol/l

0.41

792

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

297

1879

1.03

0.20

1.3

1.2

0.65

1.45

nmol/l

0.67

290

1804

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

297

1879

1.03

0.20

1.3

1.2

0.65

1.45

nmol/l

0.67

290

1804

Oral lichen ruber planus

115

0.78

0.20

1.1

1.3

0.57

0.62

nmol/l

—

107

Bacterial pneumonia (organism specified)

227

2141

0.97

0.20

1.3

4.38

2.02

nmol/l

0.27

213

2061

L02BX Other hormone antagonists and related agents

154

0.84

0.19

2.5

1.3

0.79

0.65

nmol/l

0.63

145

Assault by unspecified means

1.24

0.19

1.0

1.4

0.57

0.59

nmol/l

—

Acute poliomyelitis

1.13

0.18

1.5

1.2

1.03

0.61

nmol/l

—

Benign neoplasm: Skin of lip

1.13

0.18

1.8

1.3

0.60

0.56

nmol/l

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

1.13

0.18

1.2

1.3

0.62

0.57

nmol/l

—

Malignant neoplasm of brain

121

0.83

0.18

1.7

1.4

0.87

0.62

nmol/l

—

112

Benign neoplasm: Vagina

1.17

0.18

1.1

1.2

0.70

0.62

nmol/l

—

Small cell lung cancer

1.17

0.18

1.6

1.2

0.50

0.63

nmol/l

—

Small cell lung cancer, helper endpoint

1.17

0.18

1.6

1.2

0.50

0.63

nmol/l

—

Anorexia

1.15

0.17

1.1

1.3

0.64

0.50

nmol/l

—

Benign neoplasm: Short bones of upper limb

1.15

0.17

1.0

1.3

0.54

0.56

nmol/l

—

Schizophrenia, schizotypal and delusional disorders

187

1805

1.04

0.17

1.3

0.65

2.12

nmol/l

1.01

174

1745

Burn and corrosion of wrist and hand

138

1.16

0.17

1.3

1.4

0.60

0.58

nmol/l

0.10

132

UC patients in KELA-register (code 208), prior to 1994

195

1.13

0.17

1.1

1.3

0.68

0.67

nmol/l

0.10

185

Glucosamine medication

313

2434

1.03

0.16

1.2

1.3

0.67

2.15

nmol/l

1.32

295

2334

Disorders of oesophagus in diseases classified elsewhere

1.16

0.16

1.8

1.2

0.84

0.64

nmol/l

—

Meningitis

215

1.12

0.16

1.3

0.54

0.62

nmol/l

0.58

205

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

183

0.87

0.16

1.1

1.2

0.68

0.66

nmol/l

0.13

176

Melanocytic naevi of scalp and neck

1.20

0.16

1.1

1.3

0.63

0.59

nmol/l

0.19

Delivery

280

1441

1.03

0.16

1.2

1.3

0.61

1.50

nmol/l

0.76

272

1372

Oral leukoplakia, including avohilmo

111

1.17

0.16

1.2

1.3

0.56

0.66

nmol/l

0.86

101

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

0.79

0.15

1.2

0.50

0.64

nmol/l

—

Other and specified injuries of hip and thigh

0.79

0.15

1.0

1.2

0.63

0.54

nmol/l

—

Burn and corrosion of head and neck

0.77

0.15

1.2

1.3

0.50

0.56

nmol/l

—

Superficial injury of shoulder and upper arm

514

0.93

0.15

1.1

1.3

0.51

0.61

nmol/l

1.51

494

Acute alcohol intoxication

127

1222

1.04

0.15

1.2

1.3

0.61

2.56

nmol/l

0.90

120

1173

Diabetic retinopathy

230

1411

1.03

0.15

1.3

1.4

5.16

1.21

nmol/l

0.42

222

1357

Exposure to smoke, fire and flames

0.80

0.14

1.0

1.3

0.46

0.54

nmol/l

—

Delivery, wide proxy

221

1142

1.03

0.14

1.2

1.3

0.64

1.00

nmol/l

0.48

214

1080

Dental caries 2 and operation codes

515

4019

1.02

0.14

1.3

0.55

1.28

nmol/l

1.17

496

3869

Acute alcohol intoxication, ICD10

939

1.04

0.14

1.2

1.3

0.61

3.13

nmol/l

0.89

904

Rheumatoid arthritis, including avohilmo

237

2309

1.03

0.14

1.3

0.64

1.76

nmol/l

0.98

225

2217

Non-follicular lymphoma

398

0.93

0.14

1.3

0.68

0.67

nmol/l

0.05

376

Erythema intertrigo

0.83

0.13

1.3

0.56

0.60

nmol/l

—

Drug-induced cataract

0.83

0.13

1.8

1.2

100.49

0.60

nmol/l

—

Oesophageal obstruction

103

1.17

0.13

1.6

1.2

0.73

0.66

nmol/l

0.31

Diffuse large B-cell lymphoma

170

0.88

0.13

1.5

1.3

0.77

0.66

nmol/l

0.21

160

Serous carcinoma of ovary

180

0.89

0.13

1.1

1.3

0.68

nmol/l

0.00

172

Other disorders of iris and ciliary body

1.17

0.13

1.1

1.2

0.65

0.59

nmol/l

0.42

Chronic iridocyclitis

209

1.10

0.13

1.0

1.3

0.65

0.63

nmol/l

0.06

198

Other congenital malformations of the digestive system

160

1.12

0.13

1.6

1.2

0.44

0.56

nmol/l

2.53

152

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

355

0.93

0.12

1.2

1.3

0.64

3.88

nmol/l

0.50

340

Seropositive rheumatoid arthritis, strict definition

805

1.04

0.12

1.3

0.66

2.58

nmol/l

0.69

770

Colorectal adenocarcinoma

874

1.04

0.12

1.3

0.63

0.66

nmol/l

0.48

836

Other and unspecified nonorganic psychotic disorders

102

983

1.04

0.12

1.2

1.3

0.66

0.55

nmol/l

2.02

952

Non-allergic asthma

395

1.06

0.11

1.4

1.3

0.65

0.63

nmol/l

0.08

381

Benign neoplasm: Skin of ear and external auricular canal

147

0.88

0.11

1.3

1.2

0.62

0.63

nmol/l

0.09

139

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

153

1.11

0.11

1.2

0.64

0.67

nmol/l

0.21

148

Coronary angioplasty

190

1423

1.03

0.11

1.3

6.26

1.88

nmol/l

0.37

182

1354

Short Achilles tendon (acquired)

105

1.14

0.11

1.1

1.2

0.66

0.63

nmol/l

0.10

Hydrocephalus

301

0.93

0.10

1.9

1.2

0.70

0.68

nmol/l

0.08

283

Benign neoplasm: Parotid gland

348

1.06

0.10

1.1

1.3

0.67

0.64

nmol/l

0.25

334

Mumps

115

1.13

0.10

1.2

1.4

0.59

0.60

nmol/l

0.05

107

Melanocytic naevi of scalp and neck

1.15

0.10

1.1

1.4

0.63

0.54

nmol/l

0.60

Diffuse brain injury

1.15

0.10

1.1

1.4

0.56

0.62

nmol/l

0.34

HSIL lesion of the cervix uteri, vagina or vulva

107

1037

1.03

0.10

1.1

1.2

0.50

1.65

nmol/l

0.53

101

1005

Benign neoplasm: Appendix

1.14

0.10

1.2

0.62

0.55

nmol/l

—

Contact with other sharp object(s)

261

1.07

0.10

1.5

1.3

0.46

0.57

nmol/l

1.73

251

Melanoma in situ of trunk

1.09

0.09

1.4

1.2

0.66

0.54

nmol/l

—

Normal-pressure hydrocephalus

176

0.91

0.09

2.1

1.2

0.78

0.67

nmol/l

0.34

161

Mature T/NK-cell lymphomas, hilmo

1.04

0.09

1.2

1.3

0.74

0.55

nmol/l

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

1.04

0.09

1.2

1.3

0.74

0.58

nmol/l

—

Other and unspecified mental retardation

1.04

0.09

1.0

1.3

0.54

0.53

nmol/l

—

Memory loss

399

1.05

0.09

1.3

0.70

0.69

nmol/l

0.09

377

All dysplastic lesions of the cervix uteri

134

1370

0.98

0.09

1.2

0.49

1.67

nmol/l

0.75

129

1330

Third [oculomotor] nerve palsy

1.03

0.08

2.0

1.3

0.80

0.57

nmol/l

—

Hypothermia

0.80

0.08

1.0

1.2

0.36

0.58

nmol/l

—

Cerebral palsy

0.80

0.08

1.2

1.4

0.36

0.54

nmol/l

—

Certain zoonotic bacterial diseases

0.77

0.08

1.2

1.3

0.54

nmol/l

—

Acute otitis externa, noninfective

1.09

0.08

1.0

1.3

0.56

0.53

nmol/l

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.05

0.08

1.1

1.3

0.59

nmol/l

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

1.08

0.07

1.1

1.4

0.46

0.64

nmol/l

—

Carcinoma in situ of skin of scalp and neck

1.08

0.07

1.6

1.3

0.73

0.59

nmol/l

—

Viral pneumonia (known virus, not influenza)

1.07

0.07

1.4

1.3

0.65

0.57

nmol/l

—

Coxarthrosis, primary, with hip surgery

268

2504

1.01

0.07

1.3

3.81

1.78

nmol/l

0.28

254

2392

Other/unspecified rheumatoid arthritis

611

0.97

0.07

1.2

1.3

0.60

2.54

nmol/l

0.52

584

Other embolism and thrombosis

619

1.03

0.07

1.3

0.56

0.64

nmol/l

1.08

596

Communicating hydrocephalus

0.86

0.07

1.3

1.2

0.54

0.57

nmol/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.85

0.07

1.4

1.3

0.58

0.55

nmol/l

—

Bacterial pneumonia, not elsewhere classified

200

1798

0.98

0.07

1.3

4.87

2.28

nmol/l

0.26

188

1729

Dental caries 2

521

4055

1.01

0.07

1.3

0.55

1.28

nmol/l

1.17

503

3905

Pedestrian injured in collision with car, pick-up truck or van

0.88

0.06

1.1

1.3

0.53

0.58

nmol/l

—

Problems related to social environment

0.88

0.06

1.6

1.3

0.49

0.52

nmol/l

—

Coronary revascularization (ANGIO or CABG)

249

1713

1.01

0.06

1.3

4.87

1.78

nmol/l

0.33

240

1635

Benign neoplasm: Other and unspecified parts of mouth

138

1.09

0.06

2.3

1.3

0.74

0.63

nmol/l

0.41

127

Benign neoplasm: Skin of ear and external auricular canal

142

0.91

0.06

1.3

1.2

0.62

0.59

nmol/l

0.11

133

Syphilis

103

0.87

0.06

1.2

1.4

0.40

0.62

nmol/l

—

Injuries to the hip and thigh

252

2279

1.01

0.05

1.3

3.95

1.95

nmol/l

0.26

243

2181

Erosion and ectropion of cervix uteri

139

1.08

0.05

1.4

1.2

0.71

8.87

nmol/l

0.49

134

Benign neoplasm: Parotid gland

356

1.04

0.05

1.1

1.3

0.67

0.64

nmol/l

0.20

339

Embedded and impacted teeth

120

1037

0.98

0.05

1.5

1.3

0.46

0.50

nmol/l

0.61

114

1003

Other and unspecified corneal deformities and disorders

130

1.08

0.04

1.1

1.3

0.58

0.64

nmol/l

0.40

123

Sequelae of other and unspecified infectious and parasitic diseases

251

0.96

0.04

1.0

1.4

0.62

0.59

nmol/l

0.29

243

Other and unspecified epidermal thickening

109

0.92

0.04

1.1

1.3

0.53

0.58

nmol/l

—

104

Bacterial pneumoniae

214

1913

0.99

0.04

1.3

4.61

2.17

nmol/l

0.26

201

1843

Non-follicular lymphoma, hilmo, excluding all cancers

379

0.98

0.02

1.3

0.68

0.65

nmol/l

0.13

365

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

151

1522

0.99

0.02

1.3

0.65

1.67

nmol/l

0.69

142

1455

Fall involving bed

1.08

0.02

1.1

1.2

0.84

0.62

nmol/l

—

Granulomatous disorders of skin and subcutaneous tissue

107

0.93

0.02

1.3

0.60

0.58

nmol/l

—

102

Seropositive rheumatoid arthritis, wide

156

1549

1.01

0.01

1.2

1.3

0.65

1.65

nmol/l

0.69

147

1481

Hepatic failure, not elsewhere classified

127

0.94

0.01

1.6

1.3

0.73

0.64

nmol/l

0.42

119

Atrial septal defect

142

1.05

0.01

1.3

0.68

0.56

nmol/l

0.71

134

Respiratory tuberculosis, not confirmed

147

0.95

0.01

1.1

1.2

0.63

0.64

nmol/l

0.04

137

Other degenerative diseases of the nervous system

120

903

1.01

0.01

1.2

1.3

0.66

0.67

nmol/l

0.18

111

860

Dental caries 2, only avohilmo

507

3992

1.00

0.00

1.2

1.3

0.56

1.29

nmol/l

1.16

487

3843

Other/unspecified seropositive rheumatoid arthritis

154

1536

1.00

0.00

1.3

0.65

1.66

nmol/l

0.69

145

1468

Medical treatment for female infertility

103

1023

1.00

0.00

1.3

1.2

0.48

1.63

nmol/l

0.53

103

993

Antepartum haemorrhage, not elsewhere classified

385

0.99

0.00

1.1

1.2

0.42

0.52

nmol/l

2.28

376

Oral lichen ruber planus, including avohilmo

321

1.00

0.00

1.5

1.3

0.64

0.65

nmol/l

0.06

307

Single spontaneous delivery

271

1441

1.00

0.00

1.2

1.3

0.62

1.50

nmol/l

0.76

262

1372

Tooth agenesis EXCLUDE clefts and syndromes

135

0.96

0.00

1.0

1.3

0.41

0.48

nmol/l

0.63

128

Chronic suppurative otitis media

284

0.99

0.00

1.2

1.3

0.57

0.63

nmol/l

0.48

271

Pedal cyclist injured in collision with motor vehicle

116

1.03

0.00

1.3

0.54

0.60

nmol/l

0.37

108

Bacterial meningitis

152

0.99

0.00

1.3

0.53

0.62

nmol/l

0.57

145

Other lesions of median nerve

1.01

0.00

1.2

0.70

0.65

nmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

151

0.99

0.00

2.3

1.3

0.74

0.64

nmol/l

0.35

141

Acute nasopharyngitis (common cold)

591

0.99

0.00

1.4

1.3

0.64

0.94

nmol/l

0.39

571

Impacted teeth

768

0.99

0.00

1.7

1.3

0.46

0.48

nmol/l

0.33

744

Varicella [chickenpox]

178

1.01

0.00

1.2

1.4

0.54

0.59

nmol/l

0.23

168

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

103

0.97

0.00

1.1

1.2

0.69

0.65

nmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

101

0.99

0.00

1.2

1.3

0.61

0.57

nmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.01

0.00

1.2

1.3

0.61

0.58

nmol/l

—

Oesophageal varices

143

0.98

0.00

1.1

1.3

0.78

0.67

nmol/l

0.34

136

Other specified/unspecified disorders of bone/cartilage

105

1.05

0.00

1.3

0.93

0.60

nmol/l

0.83

Personal history of malignant neoplasm

162

0.99

0.00

1.1

1.3

0.54

0.64

nmol/l

0.97

152

Leishmaniasis

0.00

0.0

2.2

—

0.50

—

Syndactyly

0.00

0.0

1.0

—

0.40

—

Accident to watercraft causing drowning and submersion

0.00

0.0

1.3

—

0.44

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.0

2.3

—

0.35

—

Amputation of thigh

1.01

0.00

1.1

1.2

0.73

0.58

nmol/l

—

Burn and corrosion of respiratory tract

0.00

0.0

1.2

—

0.50

—

Lichen nitidus

0.00

0.0

1.6

—

0.42

—

Disorders of puberty, other/unspecified

0.00

0.0

1.4

—

0.49

—

Endometroid carcinoma of ovary

1.02

0.00

1.0

1.1

0.74

0.62

nmol/l

—

Subclinical iodine-deficiency hypothyroidism

0.00

0.0

2.0

—

0.42

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.0

—

0.52

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.88

0.00

1.0

1.2

0.74

0.62

nmol/l

—

Discharge of firework

0.00

0.0

2.2

—

0.38

—

Chronic drug-induced interstitial lung disorders

0.00

0.0

2.2

—

0.45

—

Defect, injury or illness of face

0.00

0.0

1.2

—

0.39

—

Hypoplasia of dental enamel, prenatal

0.00

0.0

1.4

—

0.59

—

Benign neoplasm: Urethra

0.00

0.0

1.2

—

0.48

—

Carcinoma in situ of oesophagus

0.00

0.0

2.4

—

0.48

—

Mechanical strabismus

0.00

0.0

1.1

—

0.43

—

Hyphaema and other vascular disorders of iris and ciliary body

0.97

0.00

1.2

0.65

0.56

nmol/l

—

Benign neoplasm: Pineal gland

0.00

0.0

1.4

—

0.41

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

2.3

—

0.49

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

0.0

1.4

—

0.36

—

Other and unspecified disorders of sclera

0.00

0.0

2.1

—

0.37

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

2.4

—

0.36

—

Crohn's disease (strict) with PSC

0.00

0.0

1.8

—

0.48

—

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

0.00

0.0

1.5

—

0.45

—

Need for immunization against certain single viral diseases

0.00

0.0

1.2

—

0.42

—

conjunctival scars

0.00

0.0

2.1

—

0.41

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

2.0

—

0.37

—

Alcohol abuse counselling and surveillance

0.89

0.00

1.0

1.4

0.83

0.54

nmol/l

—

Nonadministration of surgical and medical care

0.00

0.0

1.2

—

0.44

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.2

—

0.47

—

conjunctival degenerations and deposits

0.94

0.00

1.8

1.4

0.79

0.65

nmol/l

—

Huntington disease

0.00

0.0

1.2

—

0.40

—

Explosion and rupture of other specified pressurized devices

0.00

0.0

1.9

—

0.44

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.0

—

0.44

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

1.5

—

0.60

—

Portal vein thrombosis

0.91

0.00

1.0

1.3

0.97

0.55

nmol/l

—

Melanocytic naevi of eyelid, including canthus

1.00

0.00

2.8

1.3

0.62

0.50

nmol/l

—

Other overlap syndromes

0.88

0.00

1.3

1.2

0.47

0.54

nmol/l

—

Malignant neoplasm of vagina

0.00

0.0

1.1

—

0.49

—

Other and unspecified hydrocephalus

0.97

0.00

1.0

1.3

0.65

0.58

nmol/l

—

Frostbite with tissue necrosis

0.00

0.0

2.0

—

0.43

—

Burns and corrosions of multiple and unspecified body regions

0.89

0.00

1.0

1.4

0.50

0.54

nmol/l

—

Disorders of glycoprotein metabolism

0.00

0.0

1.2

—

0.30

—

Atypical mycobacterium lung infection

1.02

0.00

1.6

1.3

0.46

0.60

nmol/l

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

1.01

0.00

1.6

1.2

0.50

0.66

nmol/l

—

Glycosuria

0.00

0.0

1.4

—

0.50

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.6

—

0.43

—

Melanocytic naevi of upper limb, including shoulder

0.99

0.00

1.6

1.3

0.96

0.52

nmol/l

—

Use of trihexyphenidyl

0.00

0.0

1.3

—

0.53

—

Congenital malformations of nose

0.00

0.0

3.0

—

0.48

—

Congenital deformities of hip

0.89

0.00

1.0

1.3

0.33

0.52

nmol/l

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.0

1.2

—

0.45

—

Progressive external ophthalmoplegia

0.00

0.0

1.2

—

0.42

—

Drug-induced osteoporosis with pathological fracture

0.85

0.00

1.0

1.3

0.66

0.62

nmol/l

—

0.00

0.0

1.5

—

0.55

—

Feeding problems of newborn

0.00

0.0

1.1

—

0.70

—

Other disorders of choroid

1.02

0.00

2.0

1.4

0.72

0.58

nmol/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.92

0.00

1.0

1.4

0.60

0.52

nmol/l

—

Other histiocytosis syndromes

0.00

0.0

1.2

—

0.44

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.0

2.4

—

0.44

—

Benign neoplasm: Ureter

0.00

0.0

1.2

—

0.56

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

0.0

1.6

—

0.46

—

Melanocytic naevi of upper limb, including shoulder

0.98

0.00

1.6

1.3

0.96

0.59

nmol/l

—

Benign neoplasm: Skin of lip

0.97

0.00

1.8

1.3

0.60

0.58

nmol/l

—

Dyshidrosis [pompholyx]

0.97

0.00

1.0

1.4

0.53

0.54

nmol/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.0

3.1

—

0.80

—

Spinal enthesopathy

1.01

0.00

1.3

1.2

0.70

0.61

nmol/l

—

Carcinoma in situ of oesophagus

0.00

0.0

2.2

—

0.50

—

Flexion deformity

0.00

0.0

1.0

—

0.42

—

Juvenile dermatomyositis

0.00

0.0

2.0

—

0.42

—

Toxic effect of pesticides

0.00

0.0

1.2

—

0.42

—

Disorders of copper metabolism

0.00

0.0

1.8

—

0.38

—

Other and unspecified thalassaemias

0.00

0.0

1.6

—

0.46

—

Onychogryphosis

0.00

0.0

1.3

—

0.50

—

Thyroiditis, unspecified

0.98

0.00

2.4

1.3

0.80

0.55

nmol/l

—

Linear scleroderma

0.00

-0.00

0.0

1.6

—

0.46

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Normetanephrine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS